Introduction
============

Mobile health (mHealth) is one of the key areas of medical technology innovation that hold promise for reduction of cost, enhancement of health care access, and improvement in the quality of patient care \[[@ref1]-[@ref5]\]. It is also helping to shift the focus of health care to a more patient-centric model that goes beyond treating disease to a more predictive and preventative approach \[[@ref6],[@ref7]\].

Although the body of evidence that proves the potential value of mHealth is growing, there are still cases where users, mostly clinicians, resist its adoption \[[@ref8]\]. For example, scholars in the area of mHealth adoption, such as Gagnon et al \[[@ref9]\], found in a previous systematic review that, in reality, many studies reported that health care professionals perceive factors such as mHealth cost more as a barrier than a facilitator. Furthermore, Brewster et al \[[@ref10]\] reported in their systematic review on the same topic that clinicians perceive some negative impacts of mHealth on elements such as their credibility and autonomy, affecting staff acceptance of such tools. This should not be overlooked, given that previous research shows that clinicians' adoption is one of the most influential factors regarding the success of mHealth tools \[[@ref11]-[@ref15]\]; hence, the need and value of better understanding the factors impacting clinicians' adoption in this context.

The World Health Organization's global observatory of electronic health (eHealth) considers mHealth a subcategory of eHealth and defines it as "medical and public health practice supported by mobile devices, such as mobile phones, patient monitoring devices, Personal Digital Assistants (PDAs), and other wireless devices." Telemedicine is, in turn, a subcategory of mHealth and defined as "the communication or consultation between health professionals about patients using voice, text, data, imaging, or video functions of a mobile device. But it can be applied to other situations; the management of chronic diseases of patients living at home is one example." \[[@ref16]\].

According to the diffusion of innovations theory \[[@ref17]\], technology adoption studies should look into not only users' acceptance or rejection of specific innovations but also to what extent innovation is incorporated into a suitable context. Straub \[[@ref18]\] examined the most prevalent technology adoption theories---Rogers\'s innovation adoption and diffusion theories, the Concerns-Based Adoption Model, the Technology Acceptance Model (TAM), and the unified theory of acceptance and use of technology (UTAUT)---and concluded that the process of user adoption of new technologies is complex, fundamentally social, and progressive. This complexity results from the users' unique views of technology that impact their decision to adopt or reject new technology, highlighting the importance of considering social and organizational factors to enable the successful adoption of new technological tools.

We were guided in our thinking about technology adoption by the field of social studies of technology; we view technology, roles, and practices and organizational structures as interacting parts of a mutually constituting ensemble of elements \[[@ref19]-[@ref22]\]. It follows that it is not simply a matter of *factors* affecting the decision to adopt a technology or not but also of the use of technologies enabling and triggering new forms of organizing and new work practices \[[@ref23],[@ref24]\]. A *mutually constituting* sensibility alerts the researcher to the fact that the adoption of technology can be part of a deliberate change process and can result in new practices and different uses and interpretations of the technology itself. We are mindful of how such things as organizational culture and existing roles and practices are implicated not just in the decision to adopt but how the decision to adopt can lead to experimentation with new practices and organizational forms. The scope of our literature review engages in more depth with these broader concerns and interests than previous reviews.

A systematic review of relevant literature was carried out to provide an accurate and up to date account of factors that impact clinicians' adoption of mHealth tools both from a technology and a social and organizational perspective. This work complements a larger ongoing research project and supplements its initial findings, which have already been published \[[@ref25]\].

In light of Leonardi's *Methodological Guidelines for the Study of Materiality and Affordances* \[[@ref22]\], the authors analyzed the included studies following three key steps: (1) identifying utility and limitations of the studied solutions, (2) recognizing the real constraints upon opportunities faced by clinicians when using them, and (3) understanding the workflow advantages and disadvantages related to them, as reported in the included articles.

Findings from this review should benefit mHealth providers and policymakers by presenting them with an up to date and comprehensive review of key factors impacting clinicians' adoption of mHealth tools, as reported in the academic literature. This can inform and guide them in the development of a strategy for promoting the adoption of these tools and enable them to realize their potential benefits.

Methods
=======

Overview
--------

The methods for this review were drawn from the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines \[[@ref26]\]and the Cochrane Handbook \[[@ref27]\], both of which provide guidance toward a rigorous and reliable literature review methodology. The review methods were defined in advance and the protocol was published in the PROSPERO (International Prospective Register of Systematic Reviews) and is available on their website \[[@ref28]\]. The analysis did not necessitate any major divergence from the initial protocol.

The key question that guided this review was the following: "According to the literature, what are the social, organizational and technological factors impacting clinicians\' adoption of mHealth tools?"

Search Strategy
---------------

A search of MEDLINE, PubMed, the Cochrane Library, and the SAGE database in August and September 2018 identified the relevant studies. The scope was narrowed to studies published in the English language between January 2008 and August 2018. Only original, peer-reviewed, and published papers were included. Other forms, such as editorials, unsystematic reviews, interviews, comments, unstructured observations, and position papers, were excluded.

It was decided not to include articles on the basis of on hand searches of reference lists for causes summarized in the Cochrane Handbook: "positive studies are more likely to be cited" and "retrieving literature by scanning reference lists may thus produce a biased sample of studies" \[[@ref27]\].

The search string shown in [Figure 1](#figure1){ref-type="fig"} was developed according to the participants, intervention, comparators, and outcome (PICO) framework \[[@ref29]\]. There were no limitations on the kinds of conditions qualified for inclusion, and both qualitative and quantitative studies were included. Comparators were not applicable to this study. Participants (Clinicians) included studies focusing on clinicians and health care professionals. For the review, the Merriam-Webster dictionary's definition of the word *clinician* was used: "a person qualified in the clinical practice of medicine, psychiatry, or psychology as distinguished from one specializing in laboratory or research techniques or in theory" \[[@ref30]\]. Interventions (mHealth) included studies involving smart device use, such as mHealth apps or telehealth. Outcomes (Adoption) included studies addressing the factors impacting mHealth technology adoption or use.

![The search string according to the participants, intervention, comparator, and outcome (PICO) framework. mHealth: mobile health.](mhealth_v8i2e15935_fig1){#figure1}

Study Selection
---------------

Independent researchers, CJ and ASV, were involved in the screening, eligibility, and inclusion phases, and any divergences were agreed in discussion between the 2. In the cases where they could not reach an agreement, a third reviewer, CI, discussed it with them and took the final decision. The research team used the open-source app Rayyan QCRI (Qatar Computing Research Institute) to facilitate collaborative screening by the team \[[@ref31]\]. Screening lasted from August 2018 to February 2019. A screenshot of the app is included in [Multimedia Appendix 1](#app1){ref-type="supplementary-material"}.

The inclusion and exclusion criteria, detailed in [Textbox 1](#box1){ref-type="boxed-text"}, were also developed according to the PICO framework. Studies were excluded if they did not involve the use of mHealth or smart devices; focused solely on, for example, patients, caregivers or technology providers, not including clinicians; were not peer-reviewed; were editorials, interviews, comments, unstructured observations, or position papers; did not address the factors impacting adoption; or if the full text was not available, freely available, or available in English.

After completing the screening, and resolving any conflicting views between the researchers, the selected full texts were assessed for eligibility by CJ and AV, independently. Any disagreements were resolved by discussing with CI.

Subsequently, the risk of bias was assessed using the Critical Appraisal Skills Program tool \[[@ref32]\]. The checklist is included in [Multimedia Appendix 2](#app2){ref-type="supplementary-material"}, and an Excel sheet with the appraisal of the included studies can be accessed in [Multimedia Appendix 3](#app3){ref-type="supplementary-material"}. On the basis of the appraisal, 38 out of the 171 studies did not report a clear participant recruitment strategy, 40 papers did not give enough details on their data collection techniques, 76 did not clarify how they addressed potential ethical considerations, and 25 were not clear enough about their data analysis strategy and whether it was sufficiently rigorous. Articles were not excluded on the basis of technical quality to enable the researchers to capture both theoretical and empirical contributions from the published studies.

###### Inclusion and exclusion criteria according to the participants, intervention, comparator, and outcome (PICO) framework.

**Population (P)**

-   Include: Focused on health care professionals (eg, physicians and nurses).

-   Exclude: Focused only on patients, caregivers, or technology providers.

**Intervention (I)**

-   Include: Focused on solutions involving a smart device (eg, mHealth apps and telehealth).

-   Exclude: Using other technologies (eg, virtual reality and machine learning).

**Comparators (C)**

-   Does not apply.

**Outcome (O)**

-   Include: Addresses factors impacting clinicians' adoption, acceptance, use, experience, implementation, usability, or attitude of using mHealth for health care service delivery, regardless of the condition.

-   Exclude: Focused only on mHealth success or development in general.

**Publication type**

-   Include: Original, peer-reviewed, and published paper.

-   Exclude: Editorials, interviews, comments, unstructured observations, and position papers, or similar publications.

Data Collection and Synthesis
-----------------------------

The variety of measures and outcomes that were identified in the included articles were not homogenous enough to enable a quantitative synthesis of the data. Therefore, a narrative synthesis was used and structured around the organizational and technological factors impacting clinicians' adoption of mHealth solutions. QSR NVivo, a computer-assisted qualitative data analysis software, was used to assist in this task.

Data coding began with an initial data extraction grid that included themes based on previous research and technology acceptance frameworks; more themes were added as they emerged during the review process. Braun and Clarke's thematic analysis \[[@ref33]\] was used to identify and extract themes that addressed the review's research question. The phases of the thematic analysis are explained in detail in [Multimedia Appendix 4](#app4){ref-type="supplementary-material"}.

The research themes were also guided by Leonardi's *Methodological Guidelines for the Study of Materiality and Affordances* \[[@ref22]\]; hence, they were split into two key groups, on the one hand, the technological factors, and on the other the social and organizational factors. There was an additional category for implications for social and organizational practices. This process lasted from February to July 2019.

Results
=======

Overview
--------

As shown in the study selection flow diagram, visualized in [Figure 2](#figure2){ref-type="fig"}, the search string yielded a total of 4993 studies, out of which 3516 from PubMed, 1296 from SAGE, and 181 from the Cochrane database. From these, 1156 studies were excluded after limiting the scope to studies published in English and published after January 2008, leaving 3837 studies for screening. Screening of the titles and abstracts excluded another 3458 articles because 493 of them did not involve mHealth or smart devices, 531 focused solely on nonclinician populations such as patients, caregivers, or technology providers, 271 were editorials, interviews, comments, unstructured observations, position, or non--peer-reviewed papers, 2 were not available as full text, 2 were not available in English, 2119 did not address factors impacting adoption, and 40 were duplicates.

In the eligibility phase, 338 articles were included for full-text assessment. In total 167 articles were excluded for the following reasons: 28 for not involving mHealth or smart devices; 9 for focusing solely on nonclinician populations such as patients, caregivers, or technology providers; 6 for being either, editorials, interviews, comments, unstructured observations, position, or non--peer-reviewed papers; 4 because the full text was not available; and 120 for not addressing the factors impacting adoption. This resulted in the inclusion of 171 studies in the qualitative synthesis.

![Study selection flow diagram on the basis of the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines.](mhealth_v8i2e15935_fig2){#figure2}

Characteristics of Included Studies
-----------------------------------

The sample characteristics of the included articles are detailed in [Table 1](#table1){ref-type="table"}. Overall, 62 studies focused on clinicians, 41 on physicians, 21 on nurses, and 46 included clinicians and other populations such as patients or caregivers. From a specialization perspective, some were more represented than others in the included studies; 17 studies focused on primary and acute care, 12 on chronic obstructive pulmonary disease, or congestive heart failure, or cardiovascular disease, 10 on diabetes, 9 on general and family practices, 8 on psychology and mental health, whereas the other specialties were represented four times or less in the included studies.

The majority of the publications did not mention the use of a theoretical framework. Among those that used one, the TAM was the most common (n=19), followed by the theory of diffusion of innovation (n=11), and the UTAUT (n=6). Other models were used once or twice, as detailed in [Table 1](#table1){ref-type="table"}. From a geographical perspective, 38 studies were conducted in the United States, 22 in the United Kingdom, 15 in Australia, 9 in Canada, 7 in Germany, 7 in Spain, whereas other geographies were covered in 4 studies or less.

Finally, 31 studies were identified as pilot projects. Such studies can be particularly relevant to mHealth providers when rolling out a new tool, as they provide insights into the potential *teething problems* that they can avoid to have better chances for success.

###### 

Characteristics of included studies.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study characteristic         References                                                                                           
  ---------------------------- ---------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Study Design**                                                                                                                  

  \                            Qualitative (n=64)                                                                                   \[[@ref1],[@ref2],[@ref4],[@ref34]-[@ref94]\]

  \                            Quantitative (n=58)                                                                                  \[[@ref3],[@ref95]-[@ref150]\]

  \                            Mixed methods (n=32)                                                                                 \[[@ref151]-[@ref181]\]

  \                            Systematic review (n=11)                                                                             \[[@ref5],[@ref9],[@ref10],[@ref182]-[@ref189]\]

  \                            Others (n=5)                                                                                         \[[@ref8],[@ref190]-[@ref193]\]

  **Sample size**                                                                                                                   

  \                            Less than 10 (n=8)                                                                                   \[[@ref67],[@ref71],[@ref76],[@ref85],[@ref88],[@ref93],[@ref171]\]

  \                            10-20 (n=41)                                                                                         \[[@ref1],[@ref2],[@ref4],[@ref10],[@ref34],[@ref37],[@ref39],[@ref40],[@ref42],[@ref46],[@ref49],[@ref50],[@ref54],[@ref56],[@ref57],[@ref61],[@ref63]-[@ref66],[@ref68],[@ref72],[@ref75],[@ref79],[@ref80],[@ref82],[@ref86],[@ref89]-[@ref92],[@ref141],[@ref150],[@ref154],[@ref157],[@ref163], [@ref180],[@ref181],[@ref183],[@ref193],[@ref194]\]

  \                            21-40 (n=30)                                                                                         \[[@ref9],[@ref35],[@ref36],[@ref41],[@ref44],[@ref45],[@ref47],[@ref51],[@ref53],[@ref55],[@ref60],[@ref62],[@ref69],[@ref70],[@ref73],[@ref74],[@ref77],[@ref78],[@ref81],[@ref95],[@ref101],[@ref110],[@ref131],[@ref135],[@ref155],[@ref165],[@ref166],[@ref172],[@ref176],[@ref195]\]

  \                            41-60 (n=11)                                                                                         \[[@ref3],[@ref48],[@ref52],[@ref58],[@ref59],[@ref84],[@ref119],[@ref153],[@ref156],[@ref175],[@ref192]\]

  \                            61-80 (n=8)                                                                                          \[[@ref38],[@ref87],[@ref114],[@ref115],[@ref137],[@ref174],[@ref191],[@ref196]\]

  \                            81-100 (n=5)                                                                                         \[[@ref97],[@ref132],[@ref146],[@ref160],[@ref179]\]

  \                            More than 100 (n=61)                                                                                 \[[@ref8],[@ref43],[@ref83],[@ref96],[@ref98]-[@ref100],[@ref102]-[@ref109],[@ref111]-[@ref113],[@ref116]-[@ref118],[@ref120]-[@ref130],[@ref133],[@ref134],[@ref136],[@ref138]-[@ref140],[@ref142]-[@ref145],[@ref147]-[@ref149],[@ref151],[@ref152],[@ref158],[@ref159], [@ref161],[@ref162],[@ref164],[@ref167]-[@ref170],[@ref173],[@ref177],[@ref190]\]

  **Sample composition**                                                                                                            

  \                            Clinicians (n=62)                                                                                    \[[@ref9],[@ref35],[@ref36],[@ref40],[@ref45],[@ref47],[@ref53],[@ref55],[@ref56],[@ref60]-[@ref62],[@ref64],[@ref66],[@ref67],[@ref69],[@ref70],[@ref73]-[@ref75],[@ref79],[@ref81],[@ref82],[@ref85],[@ref86],[@ref90],[@ref91],[@ref93],[@ref97],[@ref98],[@ref101],[@ref104],[@ref106], [@ref107],[@ref110],[@ref112],[@ref119],[@ref120],[@ref126],[@ref130],[@ref131],[@ref137]-[@ref139],[@ref141],[@ref145],[@ref147],[@ref148],[@ref154],[@ref159],[@ref164],[@ref168],[@ref171],[@ref179],[@ref180],[@ref186],[@ref189],[@ref191],[@ref193],[@ref194]\]

  \                            Clinicians plus others (eg, patients) (n=46)                                                         \[[@ref2],[@ref4],[@ref5],[@ref8],[@ref34],[@ref38],[@ref41],[@ref43],[@ref48],[@ref51],[@ref52],[@ref58],[@ref59],[@ref68],[@ref78],[@ref83],[@ref84],[@ref87],[@ref92],[@ref94],[@ref103],[@ref115],[@ref117],[@ref151]-[@ref153],[@ref155]-[@ref158],[@ref160],[@ref162],[@ref163],[@ref166],[@ref167],[@ref169], [@ref174],[@ref176]-[@ref178],[@ref182]-[@ref184],[@ref187],[@ref192],[@ref195]\]

  \                            Physicians (n=41)                                                                                    \[[@ref1],[@ref3],[@ref37],[@ref39],[@ref46],[@ref49],[@ref50],[@ref54],[@ref77],[@ref89],[@ref95],[@ref99],[@ref100],[@ref102],[@ref105],[@ref108],[@ref113],[@ref114],[@ref116],[@ref118],[@ref121]-[@ref123],[@ref125],[@ref127]-[@ref129],[@ref132]-[@ref134],[@ref136],[@ref140],[@ref143], [@ref144],[@ref149],[@ref150],[@ref161],[@ref165],[@ref170],[@ref175],[@ref190]\]

  \                            Nurses (n=21)                                                                                        \[[@ref10],[@ref42],[@ref44],[@ref63],[@ref71],[@ref72],[@ref76],[@ref88],[@ref96],[@ref109],[@ref111],[@ref124],[@ref135],[@ref142],[@ref146],[@ref172],[@ref173],[@ref181],[@ref185],[@ref188],[@ref196]\]

  **Specialty or condition**                                                                                                        

  \                            Primary or acute care (n=17)                                                                         \[[@ref1],[@ref42],[@ref43],[@ref48],[@ref59],[@ref68],[@ref72],[@ref94],[@ref103],[@ref130],[@ref132],[@ref139],[@ref169],[@ref183],[@ref184],[@ref187],[@ref192]\]

  \                            Chronic obstructive pulmonary disease, congestive heart failure, and cardiovascular disease (n=12)   \[[@ref10],[@ref41],[@ref52],[@ref71],[@ref78],[@ref80],[@ref83],[@ref97],[@ref104],[@ref108],[@ref119],[@ref164]\]

  \                            Diabetes (n=10)                                                                                      \[[@ref38],[@ref51],[@ref75],[@ref88],[@ref92],[@ref115],[@ref125],[@ref147],[@ref160],[@ref162]\]

  \                            General and family practice (n=9)                                                                    \[[@ref39],[@ref49],[@ref89],[@ref102],[@ref117],[@ref121],[@ref128],[@ref134],[@ref144]\]

  \                            Psychology and mental health (n=8)                                                                   \[[@ref2],[@ref73],[@ref81],[@ref90],[@ref112],[@ref153],[@ref166],[@ref194]\]

  \                            Dermatology (n=4)                                                                                    \[[@ref1],[@ref54],[@ref126],[@ref152]\]

  \                            Substance use recovery (n=4)                                                                         \[[@ref61],[@ref67],[@ref158],[@ref167]\]

  \                            Residential aged care, home health nursing (n=4)                                                     \[[@ref146],[@ref156],[@ref171],[@ref182]\]

  \                            Pediatric, maternal (n=4)                                                                            \[[@ref57],[@ref74],[@ref141],[@ref168]\]

  \                            Neurology, stroke (n=4)                                                                              \[[@ref69],[@ref123],[@ref150],[@ref176]\]

  \                            Intensive care unit (n=4)                                                                            \[[@ref109],[@ref111],[@ref186],[@ref188]\]

  \                            Asthma (n=3)                                                                                         \[[@ref70],[@ref77],[@ref84]\]

  \                            Oncology (n=3)                                                                                       \[[@ref53],[@ref155],[@ref180]\]

  \                            Sexual health, HIV (n=3)                                                                             \[[@ref138],[@ref163],[@ref177]\]

  \                            Others (n=13)                                                                                        Ambulatory care \[[@ref149]\], cognitive behavioral therapy \[[@ref120]\], emergency \[[@ref159]\], genetics \[[@ref91]\], geriatrics \[[@ref40],[@ref60]\], hypertension \[[@ref5]\], nephrology \[[@ref87]\], obesity and irritable bowel syndrome \[[@ref36]\], otolaryngology \[[@ref100]\], radiology \[[@ref131]\], speech-language pathology \[[@ref50]\], tuberculosis \[[@ref58]\]

  **Location**                                                                                                                      

  \                            The United States (n=38)                                                                             \[[@ref1],[@ref2],[@ref36],[@ref45],[@ref53],[@ref54],[@ref57],[@ref60],[@ref61],[@ref67],[@ref68],[@ref75],[@ref77],[@ref88],[@ref93],[@ref99],[@ref102],[@ref109]-[@ref112],[@ref120],[@ref121],[@ref123],[@ref127],[@ref137],[@ref138],[@ref141],[@ref159],[@ref166]-[@ref169], [@ref173],[@ref194]-[@ref196]\]

  \                            The United Kingdom (n=22)                                                                            \[[@ref10],[@ref41],[@ref43],[@ref48],[@ref49],[@ref55],[@ref62],[@ref70],[@ref71],[@ref79],[@ref80],[@ref83],[@ref94],[@ref115],[@ref124],[@ref154],[@ref163],[@ref165],[@ref174],[@ref176],[@ref179],[@ref180]\]

  \                            Australia (n=15)                                                                                     \[[@ref39],[@ref42],[@ref50],[@ref51],[@ref69],[@ref73],[@ref81],[@ref91],[@ref92],[@ref103],[@ref153],[@ref156],[@ref161],[@ref164],[@ref171]\]

  \                            Canada (n=9)                                                                                         \[[@ref3],[@ref52],[@ref76],[@ref78],[@ref87],[@ref146],[@ref155],[@ref178],[@ref192]\]

  \                            Germany (n=7)                                                                                        \[[@ref100],[@ref108],[@ref117],[@ref134],[@ref135],[@ref149],[@ref150]\]

  \                            Spain (n=7)                                                                                          \[[@ref59],[@ref97],[@ref122],[@ref126],[@ref132],[@ref139],[@ref143]\]

  \                            Norway (n=4)                                                                                         \[[@ref85],[@ref86],[@ref89],[@ref90]\]

  \                            South Korea (n=4)                                                                                    \[[@ref8],[@ref107],[@ref114],[@ref129]\]

  \                            Sweden (n=4)                                                                                         \[[@ref46],[@ref72],[@ref82],[@ref175]\]

  \                            Austria (n=3)                                                                                        \[[@ref98],[@ref160],[@ref191]\]

  \                            Iran (n=3)                                                                                           \[[@ref131],[@ref147],[@ref170]\]

  \                            The Netherlands (n=3)                                                                                \[[@ref84],[@ref142],[@ref152]\]

  \                            Taiwan (n=3)                                                                                         \[[@ref35],[@ref113],[@ref116]\]

  \                            Others (n=39)                                                                                        Argentina \[[@ref44]\], Australia--United Kingdom \[[@ref65]\], Austria--Sweden \[[@ref140]\], Bangladesh \[[@ref56]\], Belgium \[[@ref162]\], Brazil \[[@ref37]\], Congo \[[@ref193]\], Ethiopia \[[@ref105]\], Europe \[[@ref66],[@ref119]\], France \[[@ref40],[@ref128]\], Ghana \[[@ref74]\], Iraq \[[@ref95]\], Israel--Portugal \[[@ref34]\], Italy \[[@ref158]\], Japan \[[@ref125]\], Japan--Sweden \[[@ref104]\], Jordan--Syria \[[@ref151]\], Lebanon \[[@ref190]\], Malaysia \[[@ref145]\], Nepal \[[@ref4]\], the Netherlands--Spain--United Kingdom \[[@ref38]\], New Zealand \[[@ref63],[@ref172]\], Nigeria \[[@ref106]\], North America--Europe \[[@ref130]\], Poland \[[@ref96]\], Portugal \[[@ref157]\], Russia \[[@ref58]\], Senegal \[[@ref118]\], South--North America \[[@ref148]\], Spain--Colombia--Bolivia \[[@ref133]\], Sri Lanka \[[@ref47]\], Switzerland \[[@ref181]\], Syria \[[@ref101]\], Turkey \[[@ref136],[@ref144]\], the United States--South Africa--Thailand--Peru \[[@ref177]\]

  **Theoretical framework**                                                                                                         

  \                            TAM^a^ was the most used theoretical framework (n=19)                                                \[[@ref90],[@ref97],[@ref102],[@ref111],[@ref126],[@ref127],[@ref129],[@ref132]-[@ref136],[@ref139],[@ref146],[@ref149],[@ref168],[@ref170],[@ref173],[@ref196]\]

  \                            The theory of diffusion of innovation (n=11)                                                         \[[@ref47],[@ref52],[@ref73],[@ref115],[@ref120],[@ref127],[@ref133],[@ref134],[@ref138],[@ref175],[@ref196]\]

  \                            UTAUT^b^ (n=6)                                                                                       \[[@ref38],[@ref98],[@ref106],[@ref107],[@ref142],[@ref181]\]

  \                            Others (n=23)                                                                                        Affordability, practicability, effectiveness, acceptability, safety or side effects, and equity criteria \[[@ref39]\]; Consolidated Framework for Implementation Research \[[@ref61],[@ref86],[@ref166]\]; design science research methodology \[[@ref157]\]; Giddens's concepts from structuration theory and consequence of modernity \[[@ref79]\]; organizational readiness for change model \[[@ref168]\]; organizational theory of implementation effectiveness \[[@ref169]\]; reach, effectiveness, adoption, implementation, and maintenance framework \[[@ref167]\]; sociotechnical theory \[[@ref94],[@ref192]\]; stakeholder empowered adoption model \[[@ref174]\]; the technology-organization-environment framework \[[@ref95]\]; technological frames \[[@ref46]\]; the dual-factor model \[[@ref116]\]; the normalization process theory \[[@ref65]\]; theory of change \[[@ref176]\]; theory of planned behavior \[[@ref113],[@ref132]\]; theory of reasoned action \[[@ref132],[@ref133]\]; theory of technology readiness \[[@ref133]\]; Updated DeLone and McLean Information System Success Model \[[@ref125]\]

  **Pilot projects**                                                                                                                

  \                            Studies identified as pilot projects (n=31)                                                          \[[@ref43],[@ref48],[@ref53],[@ref66],[@ref68],[@ref74],[@ref78],[@ref87]-[@ref89],[@ref94],[@ref95],[@ref98],[@ref112],[@ref114],[@ref126],[@ref137],[@ref139],[@ref158],[@ref162]-[@ref167],[@ref171],[@ref174],[@ref176],[@ref181],[@ref192],[@ref193]\]
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^TAM: Technology Acceptance Model.

^b^UTAUT: unified theory of acceptance and use of technology.

Technological Factors
---------------------

The technological factors impacting clinicians' adoption of mHealth were categorized into 8 key themes: usefulness, ease of use, design, compatibility, technical issues, content, personalization, and convenience. These were, in turn, subdivided into a total of 14 subthemes. [Figure 3](#figure3){ref-type="fig"} gives an overview of these technological factor themes and subthemes and their respective occurrence.

![Overview of technological factors and their occurrence. EHR: electronic health record.](mhealth_v8i2e15935_fig3){#figure3}

Technical issues were the most prominent factors, often related to matters such as connectivity (n=17), reliability (n=21), technical support (n=27), and technical difficulties in general (n=38). Features determining usefulness, such as expected benefits, performance expectancy, and added value, were also among the most prominent technological factors in the selected studies (n=64). Ease of use, determined by features such as effort expectancy and usability, was also quite central (n=55). Furthermore, several studies raised some concerns related to compatibility, such as interoperability issues (n=31), electronic health record (EHR) integration (n=20), and competition with existing programs (n=1).

Some design-related factors were also cited, such as layout, interface, culturally appropriate design (n=11), and the importance of patient-centered design (n=11). The tools' convenience, determined by its level of mobility and flexibility, also played a role (n=17), in addition to the trustworthiness and quality of the content (n=15), and personalization possibilities through customization and adaptability (n=7). [Table 2](#table2){ref-type="table"} details the technological factors impacting adoption, their occurrence, and the respective studies where they were identified.

###### 

Technological factors and their occurrence, with references.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Factor and subthemes   References                                                                                                                                                            
  ---------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Technical issues**                                                                                                                                                                         

  \                      Technical difficulties (n=38)                                                                                                                                         \[[@ref2],[@ref9],[@ref37],[@ref41]-[@ref44],[@ref51],[@ref54]-[@ref56],[@ref61],[@ref74],[@ref75],[@ref82],[@ref83],[@ref86],[@ref90]-[@ref92],[@ref101],[@ref109],[@ref115],[@ref128],[@ref150],[@ref156],[@ref162],[@ref163], [@ref165],[@ref172],[@ref177],[@ref181],[@ref182],[@ref186],[@ref188],[@ref189],[@ref194],[@ref197]\]

  \                      Technical support (n=27)                                                                                                                                              \[[@ref2],[@ref9],[@ref10],[@ref44],[@ref49],[@ref51],[@ref57],[@ref63],[@ref68],[@ref71],[@ref72],[@ref79],[@ref80],[@ref90],[@ref92],[@ref95],[@ref97],[@ref98],[@ref126],[@ref136],[@ref139],[@ref144],[@ref153],[@ref154],[@ref174], [@ref185],[@ref189]\]

  \                      Reliability (n=21)                                                                                                                                                    \[[@ref9],[@ref10],[@ref35],[@ref36],[@ref44],[@ref49],[@ref50],[@ref55],[@ref69],[@ref79],[@ref91],[@ref92],[@ref96],[@ref108],[@ref117],[@ref140],[@ref152],[@ref153],[@ref163],[@ref177],[@ref182]\]

  \                      Connectivity (n=17)                                                                                                                                                   \[[@ref37],[@ref38],[@ref44],[@ref50],[@ref51],[@ref55],[@ref68],[@ref74],[@ref91],[@ref95],[@ref124],[@ref130],[@ref153],[@ref164],[@ref172],[@ref181],[@ref182]\]

  **Usefulness**         \                                                                                                                                                                     

  \                      Benefit, performance expectancy, and added value (n=64)                                                                                                               \[[@ref5],[@ref9],[@ref34],[@ref35],[@ref38],[@ref39],[@ref45],[@ref47],[@ref50],[@ref55],[@ref60],[@ref61],[@ref63],[@ref64],[@ref67],[@ref69],[@ref78],[@ref84]-[@ref86],[@ref89],[@ref90],[@ref95],[@ref98],[@ref105]-[@ref108],[@ref111], [@ref112],[@ref114]-[@ref117],[@ref122],[@ref125]-[@ref127],[@ref129],[@ref132],[@ref134]-[@ref136],[@ref139],[@ref141]-[@ref147],[@ref149],[@ref150],[@ref153],[@ref156],[@ref158],[@ref163],[@ref168],[@ref170],[@ref172], [@ref173],[@ref179],[@ref188],[@ref189]\]

  **Ease of use**        \                                                                                                                                                                     

  \                      Effort expectancy and usability (n=55)                                                                                                                                \[[@ref4],[@ref5],[@ref9],[@ref10],[@ref38],[@ref42],[@ref44],[@ref52],[@ref59]-[@ref61],[@ref69],[@ref70],[@ref72],[@ref73],[@ref78],[@ref81],[@ref84],[@ref86]-[@ref89],[@ref92],[@ref105],[@ref106],[@ref110]-[@ref112],[@ref116], [@ref120],[@ref122],[@ref126],[@ref129],[@ref132],[@ref136],[@ref141],[@ref144],[@ref146],[@ref149],[@ref155],[@ref156],[@ref158],[@ref166],[@ref168],[@ref170]-[@ref173],[@ref179],[@ref181]-[@ref183], [@ref185],[@ref189],[@ref192]\]

  **Compatibility**                                                                                                                                                                            

  \                      Interoperability (n=31)                                                                                                                                               \[[@ref2],[@ref9],[@ref10],[@ref34]-[@ref36],[@ref41],[@ref53],[@ref54],[@ref59],[@ref61],[@ref66],[@ref70],[@ref72]-[@ref74],[@ref80],[@ref87],[@ref95],[@ref127],[@ref128],[@ref134],[@ref139],[@ref156],[@ref165],[@ref169],[@ref172],[@ref174], [@ref184],[@ref186],[@ref196]\]

  \                      Electronic health record integration (n=20)                                                                                                                           \[[@ref9],[@ref38],[@ref48],[@ref72],[@ref78],[@ref84],[@ref85],[@ref87],[@ref129],[@ref143],[@ref151],[@ref162],[@ref167],[@ref172],[@ref174],[@ref175],[@ref182],[@ref188]\]

  \                      Competition with existing programs (n=1)                                                                                                                              \[[@ref169]\]

  **Design**                                                                                                                                                                                   

  \                      Layout, interface, and culturally appropriate design (n=11)                                                                                                           \[[@ref9],[@ref38],[@ref41],[@ref60],[@ref73],[@ref78],[@ref83],[@ref155],[@ref171],[@ref182]\]

  \                      Patient-centered design (n=7)                                                                                                                                         \[[@ref39],[@ref77],[@ref78],[@ref159],[@ref162],[@ref166],[@ref182]\]

  **Convenience**        \[[@ref5],[@ref61],[@ref68],[@ref73],[@ref75],[@ref78],[@ref82],[@ref89],[@ref91],[@ref116],[@ref124],[@ref131],[@ref136],[@ref161],[@ref162],[@ref165],[@ref173]\]   

  \                      Mobility and flexibility (n=17)                                                                                                                                       \

  **Content**            \[[@ref9],[@ref38],[@ref48],[@ref59],[@ref66],[@ref73],[@ref81],[@ref114],[@ref117],[@ref124],[@ref144],[@ref154],[@ref165],[@ref175],[@ref192]\]                     

  \                      Trustworthiness and quality (n=15)                                                                                                                                    \

  **Personalization**    \[[@ref38],[@ref70],[@ref72],[@ref84],[@ref124],[@ref181],[@ref192]\]                                                                                                 

  \                      Customization and adaptability (n=7)                                                                                                                                  \
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Social and Organizational Factors
---------------------------------

The social and organizational factors impacting clinicians' adoption of mHealth were manifestly more numerous than the technical factors. These factors were also categorized into 8 key themes: workflow related, patient related, policy and regulations, culture or attitude or social influence, monetary factors, evidence base, awareness, and user engagement. Key themes were, in turn, divided into a total of 41 subthemes, as shown in [Figure 4](#figure4){ref-type="fig"}, which provides an overview of the social and organizational factors and their respective occurrence.

![Overview of social and organizational factors and their occurrence. mHealth: mobile health; KOL: key opinion leader.](mhealth_v8i2e15935_fig4){#figure4}

Workflow-related factors were the most prominent organizational factor in the included articles, with 17 subthemes. Training (n=80) was the most central workflow-related theme, followed by workload (n=66), workflow fit (n=60), time and cost efficiencies (n=51), collaboration and coordination (n=50), technical skills and experience (n=44), the impact on roles and responsibilities (n=40), the extent of leadership support (n=35), organizational or local infrastructure (n=33), process standardization and planning (n=26), staff competence (n=26), data access and management (n=25), changes to clinical practice (n=24), job security (n=22), incentives (n=15), impact on career and knowledge expansion (n=13), and decision making (n=8). [Table 3](#table3){ref-type="table"} details the subthemes of the workflow-related factors impacting adoption, their occurrence, and the respective studies where they were identified.

###### 

Workflow-related factors and their occurrence, with references.

  Factor                                        Subthemes                                                                             References
  --------------------------------------------- ------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Training (n=80)                               Clinicians' training to enable an efficient use and management of the tools           \[[@ref2],[@ref4],[@ref9],[@ref10],[@ref37],[@ref42]-[@ref44],[@ref49],[@ref50],[@ref52]-[@ref56],[@ref59],[@ref61],[@ref62],[@ref65],[@ref68],[@ref70]-[@ref74],[@ref77],[@ref79]-[@ref81], [@ref83],[@ref85],[@ref89],[@ref90],[@ref92]-[@ref94],[@ref96],[@ref97],[@ref103],[@ref104],[@ref111],[@ref112],[@ref120],[@ref122],[@ref126],[@ref128],[@ref129], [@ref136],[@ref139],[@ref142],[@ref143],[@ref149]-[@ref154],[@ref156],[@ref158],[@ref162],[@ref165],[@ref166],[@ref168]-[@ref173],[@ref176],[@ref179],[@ref182], [@ref183],[@ref185]-[@ref189],[@ref191],[@ref194]\]
  Workload (n=66)                               Availability and allocation of resources                                              \[[@ref2]-[@ref5],[@ref9],[@ref10],[@ref34]-[@ref37],[@ref39],[@ref41],[@ref45],[@ref46],[@ref48],[@ref49],[@ref51],[@ref53],[@ref55],[@ref59],[@ref61],[@ref62],[@ref70]-[@ref74],[@ref77]-[@ref81], [@ref83]-[@ref86],[@ref89],[@ref90],[@ref92],[@ref102],[@ref104],[@ref115],[@ref119],[@ref122],[@ref123],[@ref131],[@ref152],[@ref158]-[@ref160],[@ref162], [@ref164],[@ref169],[@ref172],[@ref174],[@ref178],[@ref181]-[@ref183],[@ref185],[@ref186],[@ref188]-[@ref190],[@ref192],[@ref195]\]
  Workflow fit (n=60)                           Improvements versus disruptions of the workflow and organization of work              \[[@ref1],[@ref8]-[@ref10],[@ref36],[@ref39],[@ref40],[@ref46],[@ref48],[@ref53],[@ref57],[@ref59],[@ref61],[@ref67],[@ref70],[@ref72]-[@ref74],[@ref78],[@ref80],[@ref81],[@ref83]-[@ref89],[@ref94], [@ref104],[@ref107],[@ref109],[@ref114],[@ref120],[@ref122],[@ref129],[@ref135]-[@ref137],[@ref141],[@ref147],[@ref150],[@ref155],[@ref156],[@ref159], [@ref161],[@ref163],[@ref166],[@ref169],[@ref171],[@ref172],[@ref178],[@ref180]-[@ref182],[@ref185],[@ref188],[@ref193]\]
  Time or cost-efficiency (n=51)                Impact on efficiency and competitiveness                                              \[[@ref1],[@ref5],[@ref9],[@ref38],[@ref39],[@ref43],[@ref44],[@ref47],[@ref49],[@ref52]-[@ref54],[@ref57],[@ref59]-[@ref61],[@ref64],[@ref74],[@ref77],[@ref78],[@ref86],[@ref87],[@ref91], [@ref94],[@ref107]-[@ref110],[@ref114],[@ref115],[@ref119],[@ref132],[@ref137],[@ref140],[@ref150],[@ref152],[@ref156],[@ref157],[@ref159],[@ref161], [@ref162],[@ref165],[@ref168],[@ref173],[@ref174],[@ref177],[@ref179],[@ref181],[@ref188],[@ref190],[@ref195]\]
  Collaboration and coordination (n=50)         Coordination of health services and collaboration between health care professionals   \[[@ref1],[@ref2],[@ref8]-[@ref10],[@ref39],[@ref40],[@ref42],[@ref46],[@ref50],[@ref52],[@ref55]-[@ref57],[@ref59],[@ref61],[@ref68],[@ref69],[@ref71],[@ref84],[@ref85],[@ref87],[@ref88], [@ref92],[@ref93],[@ref100],[@ref102],[@ref109],[@ref111],[@ref127],[@ref137],[@ref141],[@ref150],[@ref152],[@ref153],[@ref155],[@ref156],[@ref159], [@ref161],[@ref162],[@ref168],[@ref172],[@ref176],[@ref182],[@ref185],[@ref186],[@ref188],[@ref194]\]
  Technical skills, and experience (n=44)       Clinicians' tech-savviness, and previous experience with technology or mHealth^a^     \[[@ref9],[@ref37],[@ref44],[@ref49],[@ref55],[@ref59]-[@ref61],[@ref67],[@ref72],[@ref73],[@ref81],[@ref83],[@ref96],[@ref100]-[@ref102],[@ref112],[@ref121],[@ref122],[@ref127], [@ref129],[@ref133],[@ref134],[@ref136],[@ref138],[@ref142],[@ref143],[@ref145],[@ref146],[@ref149],[@ref153],[@ref155],[@ref157],[@ref158],[@ref161], [@ref168]-[@ref170],[@ref179],[@ref184],[@ref188],[@ref191],[@ref196]\]
  Roles and responsibilities (n=40)             Expansion, reassignment, or possible changes to clinical roles and responsibilities   \[[@ref2],[@ref10],[@ref39],[@ref40],[@ref48],[@ref56],[@ref59]-[@ref62],[@ref65],[@ref67],[@ref68],[@ref70]-[@ref72],[@ref74],[@ref77]-[@ref80],[@ref82],[@ref83],[@ref85],[@ref86], [@ref88]-[@ref90],[@ref94],[@ref103],[@ref104],[@ref152],[@ref157],[@ref164],[@ref167],[@ref169],[@ref176],[@ref182],[@ref189]\]
  Leadership support (n=35)                     Senior management and organizational support                                          \[[@ref5],[@ref9],[@ref34],[@ref35],[@ref40],[@ref42],[@ref59],[@ref61],[@ref71]-[@ref73],[@ref86],[@ref95],[@ref103],[@ref105],[@ref106],[@ref111],[@ref127],[@ref131],[@ref132],[@ref134], [@ref138],[@ref145],[@ref156],[@ref157],[@ref164],[@ref166],[@ref170],[@ref174],[@ref181],[@ref182],[@ref188],[@ref192],[@ref195],[@ref196]\]
  Infrastructure (n=33)                         Availability and accessibility of the needed foundation                               \[[@ref2]-[@ref4],[@ref9],[@ref35],[@ref47],[@ref51],[@ref54],[@ref69],[@ref70],[@ref77],[@ref82],[@ref83],[@ref87],[@ref91],[@ref93],[@ref95],[@ref116],[@ref124],[@ref126], [@ref127],[@ref130],[@ref151],[@ref153],[@ref154],[@ref157],[@ref163],[@ref169],[@ref172],[@ref179],[@ref181],[@ref187],[@ref193]\]
  Process standardization and planning (n=26)   Governance and control, streamlined procedures, and processes                         \[[@ref5],[@ref8],[@ref9],[@ref39],[@ref40],[@ref44]-[@ref46],[@ref61],[@ref65],[@ref67],[@ref73],[@ref80],[@ref82]-[@ref84],[@ref86],[@ref88],[@ref103],[@ref149],[@ref155], [@ref160],[@ref164],[@ref167]-[@ref169],[@ref180],[@ref182],[@ref185],[@ref189]\]
  Staff competence (n=26)                       Expertise in the required skills                                                      \[[@ref2],[@ref4],[@ref9],[@ref36],[@ref37],[@ref39],[@ref51],[@ref58],[@ref59],[@ref69],[@ref73],[@ref80],[@ref84],[@ref91],[@ref92],[@ref105],[@ref108],[@ref109],[@ref137], [@ref154]-[@ref157],[@ref164],[@ref176],[@ref185]\]
  Data access and management (n=25)             Accessing, analyzing, and interpreting generated data                                 \[[@ref36],[@ref38],[@ref51],[@ref53],[@ref60],[@ref62],[@ref66],[@ref72]-[@ref75],[@ref77],[@ref78],[@ref100],[@ref108],[@ref115],[@ref120],[@ref150],[@ref157], [@ref167],[@ref169],[@ref176],[@ref177],[@ref182],[@ref183]\]
  Changes to clinical practice (n=24)           New paradigms of care and treatment                                                   \[[@ref10],[@ref35],[@ref37],[@ref40],[@ref46],[@ref48],[@ref49],[@ref59],[@ref64],[@ref65],[@ref72],[@ref79],[@ref80],[@ref92],[@ref94],[@ref123],[@ref130],[@ref139], [@ref162],[@ref182],[@ref185],[@ref186],[@ref189],[@ref192]\]
  Job security (n=22)                           Autonomy, loss of control, threat to own career, and professional identity            \[[@ref9],[@ref10],[@ref55],[@ref62],[@ref72],[@ref79],[@ref80],[@ref108],[@ref113],[@ref116],[@ref118],[@ref124],[@ref130],[@ref140],[@ref141],[@ref151], [@ref159],[@ref176],[@ref182],[@ref185],[@ref188]\]
  Incentives (n=15)                             Different means to incentivize clinicians                                             \[[@ref4],[@ref54],[@ref59],[@ref87],[@ref88],[@ref106],[@ref122],[@ref129],[@ref141],[@ref157],[@ref164],[@ref168],[@ref175],[@ref191]\]
  Career and knowledge expansion (n=13)         Impact on professional development and expertise                                      \[[@ref62],[@ref72]-[@ref74],[@ref86],[@ref124],[@ref131],[@ref137],[@ref161],[@ref162],[@ref169],[@ref188],[@ref189]\]
  Decision making (n=8)                         The process of decision making in a fragmented health care system                     \[[@ref4],[@ref8],[@ref34],[@ref43],[@ref71],[@ref72],[@ref74],[@ref97],[@ref102],[@ref160],[@ref191]\]

^a^mHealth: mobile health.

Patient-related factors arose quite often in the included articles and were split into 13 subthemes. The most prevalent patient-related subtheme was the quality and efficiency of patient care, for example, treatment outcomes, clinical delivery, patient monitoring, and treatment compliance (n=77), followed by the quality and ease of communications between patients and the care team (n=53), enhancing patients' access to care and reaching the underserved (n=41), then patients' comfort with technology, personal preferences, and the ease of getting an informed consent from the patients (n=30). Applicability and appropriateness, meaning the suitability of patients on the basis of their needs and characteristics, also occurred quite often (n=24), seeing mHealth as an opportunity to empower and reassure patients and increase their engagement in managing their condition, which was also a key factor (n=21).

In addition to patient safety (n=19), factors included patient age, living standard, and access to technology (n=15), better patient education and awareness (n=12), patient overdependence on practitioner support (n=8), and patients' worries and anxiety related to the understanding and interpretation of data, or the feeling of being observed (n=6). The least common subthemes were those reflecting concerns regarding patients' long-term commitment and use (n=3) and protective or paternalistic attitudes of the care team (n=2). [Table 4](#table4){ref-type="table"} details the subthemes of the patient-related factors impacting adoption, their occurrence, and the respective studies where they were identified.

###### 

Patient-related factors and their occurrence, with references.

  Factor                                        Subthemes                                                                             References
  --------------------------------------------- ------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Training (n=80)                               Clinicians' training to enable an efficient use and management of the tools           \[[@ref2],[@ref4],[@ref9],[@ref10],[@ref37],[@ref42]-[@ref44],[@ref49],[@ref50],[@ref52]-[@ref56],[@ref59],[@ref61],[@ref62],[@ref65],[@ref68],[@ref70]-[@ref74],[@ref77],[@ref79]-[@ref81],[@ref83],[@ref85],[@ref89],[@ref90],[@ref92]-[@ref94], [@ref96],[@ref97],[@ref103],[@ref104],[@ref111],[@ref112],[@ref120],[@ref122],[@ref126],[@ref128],[@ref129],[@ref136],[@ref139],[@ref142],[@ref143],[@ref149]-[@ref154],[@ref156],[@ref158], [@ref162],[@ref165],[@ref166],[@ref168]-[@ref173],[@ref176],[@ref179],[@ref182],[@ref183],[@ref185]-[@ref189],[@ref191],[@ref194]\]
  Workload (n=66)                               Availability and allocation of resources                                              \[[@ref2]-[@ref5],[@ref9],[@ref10],[@ref34]-[@ref37],[@ref39],[@ref41],[@ref45],[@ref46],[@ref48],[@ref49],[@ref51],[@ref53],[@ref55],[@ref59],[@ref61],[@ref62],[@ref70]-[@ref74],[@ref77]-[@ref81],[@ref83]-[@ref86],[@ref89],[@ref90],[@ref92], [@ref102],[@ref104],[@ref115],[@ref119],[@ref122],[@ref123],[@ref131],[@ref152],[@ref158]-[@ref160],[@ref162],[@ref164],[@ref169],[@ref172],[@ref174],[@ref178],[@ref181]-[@ref183],[@ref185],[@ref186],[@ref188]-[@ref190], [@ref192],[@ref195]\]
  Workflow fit (n=60)                           Improvements versus disruptions of the workflow and organization of work              \[[@ref1],[@ref8]-[@ref10],[@ref36],[@ref39],[@ref40],[@ref46],[@ref48],[@ref53],[@ref57],[@ref59],[@ref61],[@ref67],[@ref70],[@ref72]-[@ref74],[@ref78],[@ref80],[@ref81],[@ref83]-[@ref89],[@ref94],[@ref104],[@ref107],[@ref109], [@ref114],[@ref120],[@ref122],[@ref129],[@ref135]-[@ref137],[@ref141],[@ref147],[@ref150],[@ref155],[@ref156],[@ref159],[@ref161],[@ref163],[@ref166],[@ref169],[@ref171],[@ref172],[@ref178],[@ref180]-[@ref182],[@ref185], [@ref188],[@ref193]\]
  Time or cost-efficiency (n=51)                Impact on efficiency and competitiveness                                              \[[@ref1],[@ref5],[@ref9],[@ref38],[@ref39],[@ref43],[@ref44],[@ref47],[@ref49],[@ref52]-[@ref54],[@ref57],[@ref59]-[@ref61],[@ref64],[@ref74],[@ref77],[@ref78],[@ref86],[@ref87],[@ref91],[@ref94],[@ref107]-[@ref110],[@ref114], [@ref115],[@ref119],[@ref132],[@ref137],[@ref140],[@ref150],[@ref152],[@ref156],[@ref157],[@ref159],[@ref161],[@ref162],[@ref165],[@ref168],[@ref173],[@ref174],[@ref177],[@ref179],[@ref181],[@ref188],[@ref190],[@ref195]\]
  Collaboration and coordination (n=50)         Coordination of health services and collaboration between health care professionals   \[[@ref1],[@ref2],[@ref8]-[@ref10],[@ref39],[@ref40],[@ref42],[@ref46],[@ref50],[@ref52],[@ref55]-[@ref57],[@ref59],[@ref61],[@ref68],[@ref69],[@ref71],[@ref84],[@ref85],[@ref87],[@ref88],[@ref92],[@ref93],[@ref100],[@ref102],[@ref109],[@ref111], [@ref127],[@ref137],[@ref141],[@ref150],[@ref152],[@ref153],[@ref155],[@ref156],[@ref159],[@ref161],[@ref162],[@ref168],[@ref172],[@ref176],[@ref182],[@ref185],[@ref186],[@ref188],[@ref194]\]
  Technical skills, and experience (n=44)       Clinicians' tech-savviness, and previous experience with technology or mHealth^a^     \[[@ref9],[@ref37],[@ref44],[@ref49],[@ref55],[@ref59]-[@ref61],[@ref67],[@ref72],[@ref73],[@ref81],[@ref83],[@ref96],[@ref100]-[@ref102],[@ref112],[@ref121],[@ref122],[@ref127],[@ref129],[@ref133],[@ref134],[@ref136],[@ref138], [@ref142],[@ref143],[@ref145],[@ref146],[@ref149],[@ref153],[@ref155],[@ref157],[@ref158],[@ref161],[@ref168]-[@ref170],[@ref179],[@ref184],[@ref188],[@ref191],[@ref196]\]
  Roles and responsibilities (n=40)             Expansion, reassignment, or possible changes to clinical roles and responsibilities   \[[@ref2],[@ref10],[@ref39],[@ref40],[@ref48],[@ref56],[@ref59]-[@ref62],[@ref65],[@ref67],[@ref68],[@ref70]-[@ref72],[@ref74],[@ref77]-[@ref80],[@ref82],[@ref83],[@ref85],[@ref86],[@ref88]-[@ref90],[@ref94],[@ref103],[@ref104],[@ref152], [@ref157],[@ref164],[@ref167],[@ref169],[@ref176],[@ref182],[@ref189]\]
  Leadership support (n=35)                     Senior management and organizational support                                          \[[@ref5],[@ref9],[@ref34],[@ref35],[@ref40],[@ref42],[@ref59],[@ref61],[@ref71]-[@ref73],[@ref86],[@ref95],[@ref103],[@ref105],[@ref106],[@ref111],[@ref127],[@ref131],[@ref132],[@ref134],[@ref138],[@ref145],[@ref156], [@ref157],[@ref164],[@ref166],[@ref170],[@ref174],[@ref181],[@ref182],[@ref188],[@ref192],[@ref195],[@ref196]\]
  Infrastructure (n=33)                         Availability and accessibility of the needed foundation                               \[[@ref2]-[@ref4],[@ref9],[@ref35],[@ref47],[@ref51],[@ref54],[@ref69],[@ref70],[@ref77],[@ref82],[@ref83],[@ref87],[@ref91],[@ref93],[@ref95],[@ref116],[@ref124],[@ref126],[@ref127],[@ref130],[@ref151],[@ref153],[@ref154], [@ref157],[@ref163],[@ref169],[@ref172],[@ref179],[@ref181],[@ref187],[@ref193]\]
  Process standardization and planning (n=26)   Governance and control, streamlined procedures, and processes                         \[[@ref5],[@ref8],[@ref9],[@ref39],[@ref40],[@ref44]-[@ref46],[@ref61],[@ref65],[@ref67],[@ref73],[@ref80],[@ref82]-[@ref84],[@ref86],[@ref88],[@ref103],[@ref149],[@ref155],[@ref160],[@ref164],[@ref167]-[@ref169],[@ref180], [@ref182],[@ref185],[@ref189]\]
  Staff competence (n=26)                       Expertise in the required skills                                                      \[[@ref2],[@ref4],[@ref9],[@ref36],[@ref37],[@ref39],[@ref51],[@ref58],[@ref59],[@ref69],[@ref73],[@ref80],[@ref84],[@ref91],[@ref92],[@ref105],[@ref108],[@ref109],[@ref137],[@ref154]-[@ref157],[@ref164],[@ref176],[@ref185]\]
  Data access and management (n=25)             Accessing, analyzing, and interpreting generated data                                 \[[@ref36],[@ref38],[@ref51],[@ref53],[@ref60],[@ref62],[@ref66],[@ref72]-[@ref75],[@ref77],[@ref78],[@ref100],[@ref108],[@ref115],[@ref120],[@ref150],[@ref157],[@ref167],[@ref169],[@ref176],[@ref177],[@ref182],[@ref183]\]
  Changes to clinical practice (n=24)           New paradigms of care and treatment                                                   \[[@ref10],[@ref35],[@ref37],[@ref40],[@ref46],[@ref48],[@ref49],[@ref59],[@ref64],[@ref65],[@ref72],[@ref79],[@ref80],[@ref92],[@ref94],[@ref123],[@ref130],[@ref139],[@ref162],[@ref182],[@ref185],[@ref186],[@ref189],[@ref192]\]
  Job security (n=22)                           Autonomy, loss of control, threat to own career, and professional identity            \[[@ref9],[@ref10],[@ref55],[@ref62],[@ref72],[@ref79],[@ref80],[@ref108],[@ref113],[@ref116],[@ref118],[@ref124],[@ref130],[@ref140],[@ref141],[@ref151],[@ref159],[@ref176],[@ref182],[@ref185],[@ref188]\]
  Incentives (n=15)                             Different means to incentivize clinicians                                             \[[@ref4],[@ref54],[@ref59],[@ref87],[@ref88],[@ref106],[@ref122],[@ref129],[@ref141],[@ref157],[@ref164],[@ref168],[@ref175],[@ref191]\]
  Career and knowledge expansion (n=13)         Impact on professional development and expertise                                      \[[@ref62],[@ref72]-[@ref74],[@ref86],[@ref124],[@ref131],[@ref137],[@ref161],[@ref162],[@ref169],[@ref188],[@ref189]\]
  Decision making (n=8)                         The process of decision making in a fragmented health care system                     \[[@ref4],[@ref8],[@ref34],[@ref43],[@ref71],[@ref72],[@ref74],[@ref97],[@ref102],[@ref160],[@ref191]\]

Other social and organizational factors included policy and regulations related to privacy or security or medico-legal issues (n=66) and the need for clearer guidelines or protocols or policies (n=44). Cultural and social factors also prevailed quite often and were mostly linked to perceptions and attitudes toward technology and mHealth (n=57), organizational culture and context (n=21), and endorsement or peer influence (n=21).

Monetary factors, such as funding or reimbursement or fees (n=51) and the tools' cost (n=35), were also central, followed by the strength and quality of clinical evidence (n=22), lack of awareness and promotion (n=20), and user involvement in development and planning (n=12). [Table 5](#table5){ref-type="table"} details the other social and organizational factors impacting adoption, their subthemes, occurrence, and the respective studies where they were identified.

###### 

Other social and organizational factors and their occurrence, with references.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Factor and subthemes                          References                                                          
  --------------------------------------------- ------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Policy and regulations**                                                                                        

  \                                             Privacy, security, and medico-legal issues (n=66)                   \[[@ref2],[@ref3],[@ref9],[@ref10],[@ref37]-[@ref39],[@ref44],[@ref47],[@ref49],[@ref52],[@ref53],[@ref58]-[@ref61],[@ref65],[@ref67],[@ref73],[@ref77],[@ref84],[@ref90],[@ref95],[@ref98],[@ref100],[@ref102],[@ref108], [@ref110],[@ref114],[@ref117],[@ref123],[@ref125],[@ref127],[@ref128],[@ref130]-[@ref132],[@ref137],[@ref138],[@ref140],[@ref142]-[@ref144],[@ref149],[@ref152],[@ref156],[@ref158],[@ref160]-[@ref163],[@ref167], [@ref172],[@ref174],[@ref176]-[@ref178],[@ref182]-[@ref185],[@ref189]-[@ref193]\]

  \                                             Clear guidelines, protocols, and policies (n=44)                    \[[@ref1],[@ref4],[@ref5],[@ref9],[@ref10],[@ref34],[@ref35],[@ref37],[@ref42],[@ref43],[@ref47],[@ref51],[@ref61],[@ref63],[@ref64],[@ref67],[@ref73],[@ref76],[@ref92],[@ref95],[@ref102],[@ref104],[@ref121]-[@ref124],[@ref130], [@ref141],[@ref143],[@ref145],[@ref151],[@ref155]-[@ref157],[@ref159],[@ref161],[@ref162],[@ref168],[@ref175],[@ref176],[@ref178],[@ref179],[@ref190],[@ref193]\]

  **Culture, attitude, and social influence**                                                                       

  \                                             Perceptions and attitudes toward technology and mHealth^a^ (n=57)   \[[@ref5],[@ref9],[@ref10],[@ref34],[@ref35],[@ref37],[@ref50],[@ref55],[@ref58]-[@ref61],[@ref63],[@ref64],[@ref67],[@ref69],[@ref83],[@ref85],[@ref95],[@ref97],[@ref100],[@ref104],[@ref107]-[@ref109],[@ref111], [@ref113],[@ref116]-[@ref118],[@ref124],[@ref125],[@ref127],[@ref130],[@ref132]-[@ref134],[@ref136],[@ref138],[@ref143],[@ref146],[@ref147],[@ref153],[@ref155],[@ref157],[@ref166],[@ref168],[@ref173],[@ref174], [@ref178],[@ref185],[@ref186],[@ref188],[@ref190],[@ref191],[@ref193],[@ref195]\]

  \                                             Organizational culture and context (n=21)                           \[[@ref37],[@ref42],[@ref45],[@ref63],[@ref76],[@ref86],[@ref95],[@ref101],[@ref113],[@ref124],[@ref130],[@ref145],[@ref148],[@ref151],[@ref161],[@ref165],[@ref168],[@ref170],[@ref176],[@ref179],[@ref193]\]

  \                                             Endorsement, peer influence, and key opinion leaders (n=21)         \[[@ref2],[@ref9],[@ref38],[@ref51],[@ref61],[@ref67],[@ref99],[@ref105],[@ref113],[@ref125],[@ref128],[@ref132],[@ref142],[@ref146],[@ref161],[@ref163],[@ref170],[@ref175],[@ref181],[@ref196]\]

  \                                             Infringing into personal life (n=6)                                 \[[@ref47],[@ref65],[@ref77],[@ref161],[@ref188],[@ref190]\]

  **Monetary factors**                                                                                              

  \                                             Funding, reimbursement, and fees (n=51)                             \[[@ref2]-[@ref5],[@ref8],[@ref9],[@ref35],[@ref36],[@ref39],[@ref51],[@ref54],[@ref56],[@ref60],[@ref61],[@ref64],[@ref67],[@ref68],[@ref70],[@ref71],[@ref74],[@ref77],[@ref84],[@ref86],[@ref91],[@ref92],[@ref100]-[@ref102], [@ref119],[@ref122],[@ref123],[@ref128]-[@ref131],[@ref141],[@ref143],[@ref151],[@ref152],[@ref156],[@ref159],[@ref160],[@ref162],[@ref164],[@ref167],[@ref168],[@ref182],[@ref184], [@ref186],[@ref191],[@ref195]\]

  \                                             Tool's cost (n=35)                                                  \[[@ref1],[@ref2],[@ref5],[@ref9],[@ref34],[@ref38],[@ref39],[@ref41],[@ref51],[@ref53],[@ref55],[@ref60],[@ref61],[@ref63],[@ref64],[@ref67],[@ref73],[@ref78],[@ref84],[@ref91],[@ref95],[@ref110],[@ref114],[@ref123],[@ref130]-[@ref132],[@ref142], [@ref144],[@ref147],[@ref156],[@ref159],[@ref177],[@ref182],[@ref191]\]

  **Evidence base**                             \                                                                   

  \                                             Strength and quality of clinical evidence (n=22)                    \[[@ref5],[@ref43],[@ref55],[@ref60],[@ref67],[@ref69],[@ref70],[@ref73],[@ref84],[@ref85],[@ref89],[@ref108],[@ref109],[@ref115],[@ref155],[@ref159],[@ref160],[@ref162],[@ref169],[@ref175],[@ref186],[@ref188]\]

  **Awareness**                                 \                                                                   

  \                                             Lack of awareness and promotion (n=20)                              \[[@ref2],[@ref9],[@ref38],[@ref43],[@ref55],[@ref56],[@ref61],[@ref73],[@ref89],[@ref120],[@ref131],[@ref138],[@ref149]-[@ref151],[@ref156],[@ref168],[@ref175],[@ref180],[@ref182]\]

  **User engagement**                           \                                                                   

  \                                             Involvement in development and planning (n=12)                      \[[@ref10],[@ref38],[@ref52],[@ref61],[@ref68],[@ref72],[@ref86],[@ref135],[@ref169],[@ref172],[@ref182],[@ref183]\]
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^mHealth: mobile health.

Discussion
==========

The main findings of this review emphasize the principal factors impacting clinicians' adoption of mHealth tools. Factors' prevalence sheds light on the clear importance of social and organizational factors that go beyond the technical features, highlighting the importance of taking them into account during the development and deployment of these tools.

Technological Factors
---------------------

Technical difficulties were the most cited technical barriers identified in the included articles. Studies reported technical difficulties and limitations in general, besides other issues, such as failing to update the system or testing and installation issues \[[@ref2],[@ref10],[@ref51]\], system errors \[[@ref74],[@ref163]\], poor output quality (eg, poor images or video quality) \[[@ref37],[@ref82],[@ref91],[@ref189]\], login issues \[[@ref42],[@ref86],[@ref150],[@ref172]\], and missing functionalities \[[@ref181]\]. It was reported that such issues sometimes impacted the recruitment of eligible participants \[[@ref163]\], created a feeling of frustration among users \[[@ref44],[@ref75],[@ref162]\], or made the staff more reluctant to promote the tool, as it might not work properly \[[@ref43]\], and resulted in interruption of care \[[@ref75],[@ref90],[@ref109],[@ref188]\].

Technical support availability and cooperation from the information technology (IT) department can also impact clinicians' intention to use mHealth tools. Support is, moreover, expected to be available whenever a clinical shift is active such as during the night, weekends, and holidays \[[@ref44]\]. The lack of technical support can create difficulties for the adoption, as clinical staff do not want to be expected to do the technical installation and troubleshooting themselves \[[@ref10]\]. Some concerns were raised regarding outsourced offshore technical support models that were deemed impersonal and *script-driven* and not very useful \[[@ref51]\]. Furthermore, IT departments in hospitals may not be fully prepared for supporting staff's mobile phones when these are used to access mHealth tools \[[@ref63]\]. Although some studies reported staff's satisfaction with the technical support offered to them, there were still some concerns about delayed delivery of the service because of lack of technical support staff \[[@ref71],[@ref72],[@ref79],[@ref90]\].

System reliability can also cause challenges that affect clinicians' intentions to use mHealth. System failures and malfunctions raised concern for staff \[[@ref35],[@ref140],[@ref177]\], and clinicians who are skeptical about the reliability of the service might refrain from using it altogether \[[@ref55],[@ref108]\]. Users want to be sure that it will work in every emergency even when patients are using them on their own \[[@ref69],[@ref79]\]. Similarly, poor signal connectivity linked to speed and quality of the connection can cause major usability issues making the use of such tools almost impossible \[[@ref37],[@ref44],[@ref50],[@ref95],[@ref181]\], hence diminishing the usefulness of the tool \[[@ref74]\] and resulting in frustration and reluctance to use the service \[[@ref124],[@ref153]\]. An offline functionality whenever possible could help overcome such issue \[[@ref38]\], although some clinicians did not perceive slow connections as a significant barrier \[[@ref68],[@ref130]\]. In some cases, clinical staff developed some work-around routines to overcome connectivity issues by printing the needed patient information, resulting in additional data security and privacy issues \[[@ref172]\].

Many of the included studies indicated that usefulness and perceived usefulness have a direct impact on the adoption and intention to use. Clinicians are more likely to use a tool when they understand its benefits \[[@ref34],[@ref78],[@ref86]\], when they find it useful for their daily work \[[@ref85],[@ref89],[@ref127],[@ref134],[@ref146],[@ref150],[@ref179]\], and in emergencies \[[@ref47],[@ref188]\]; they would refrain from using it if they are skeptical about the value it brings to their clinical practice \[[@ref35],[@ref60],[@ref69],[@ref84],[@ref108],[@ref115],[@ref141],[@ref153],[@ref156],[@ref158]\], sometimes because of their lack of awareness of studies demonstrating effectiveness \[[@ref90]\]. Some studies noted that the positive perception of usefulness usually increases for clinicians that use such tools more frequently \[[@ref143]\].

Studies also linked perceived usefulness in many cases to ease of use and effort expectancy. mHealth tools should be very user-friendly and intuitive so that every clinician can use them easily, including those not comfortable with technology \[[@ref4],[@ref70],[@ref73],[@ref166],[@ref189]\]; otherwise, they might be considered a waste of time \[[@ref72],[@ref156]\]. Although complex and unintuitive user interfaces are considered a clear barrier \[[@ref141],[@ref155]\], it was also noted that usability alone is not enough for user acceptance \[[@ref181]\]. This was sometimes explained by the specific context that clinicians operate in \[[@ref168]\], so ease of use could be perceived as less important in underprivileged contexts where clinicians lack resources and are grateful for any tool that would help facilitate their professional duties \[[@ref105]\].

The tools' technical compatibility also plays a role in its acceptance. Clinicians have a positive attitude toward tools that integrate well with the other systems that they are using on a daily basis \[[@ref127],[@ref196]\]. Interoperability issues can raise clear concerns when mHealth tools cannot be integrated into the hospital or clinic's current systems \[[@ref87],[@ref128]\]. Similarly, the lack of electronic medical records (EMRs) or EHR integration can cause similar issues \[[@ref9],[@ref183]\]. This can create limitations in data integration and exchange \[[@ref34],[@ref36],[@ref156],[@ref174]\] and therefore create duplication of effort and increase workload \[[@ref70],[@ref72],[@ref80]\]. Some clinicians also raised the reliability of self-reported data and the importance of validating it in comparison to the data in the patient's EMR to make informed decisions \[[@ref175]\]. Conversely, a tool that integrates well with current systems would be highly appreciated as it would ensure that patient data is always up to date and would alleviate clinicians' workload \[[@ref38],[@ref129]\].

Layout, interface, and culturally appropriate and patient-centered design came up as important influencing factors in several studies. The choice of design and color should be well informed; for example, bright colors should be avoided as they may cause seizures in people suffering from epilepsy \[[@ref38]\]. Cluttered and unorganized displays impact adoption negatively \[[@ref83],[@ref155],[@ref171]\]. Users should also be able to adapt design elements, such as font size, according to their own preference \[[@ref38]\]. Customization and personalization should also go beyond design elements to include the type of information displayed according to the context and the needs of the individual users \[[@ref124],[@ref181]\]. Furthermore, clinicians are keen to see tools that can be customized to each patients' clinical condition \[[@ref70],[@ref84]\]. Concerns were raised regarding the gap that sometimes exists between the tools' designers and users, hence the desire for the tools to be adaptable to the user needs, not the other way around \[[@ref72]\].

The convenience and mobility of tools accessed via mobile phones were mostly seen as facilitators. They also have a positive impact on perceived usefulness and ease of use \[[@ref116]\] and can increase clinicians' ability to offer care in a timely manner \[[@ref5],[@ref78]\]. The portability of mHealth tools enabling clinicians to access information and achieve tasks anytime and anywhere was highly valued \[[@ref73],[@ref131],[@ref136],[@ref161],[@ref162]\]. Conversely, it was also reported that some users perceived the small size of the mobile screen as an inconvenience that could hinder adoption \[[@ref165]\].

Social and Organizational Factors: Workflow Related
---------------------------------------------------

Workflow-related factors were the most prominent in the studied articles, with 17 subthemes. Training came up in 80 articles, showing the central role it plays in making or breaking the success of mHealth tools. Several studies identified the impact that appropriate training programs could play in increasing clinicians' intention to use such tools \[[@ref9],[@ref97],[@ref139],[@ref149],[@ref179]\].

Factors such as nonexistent, inadequate or insufficient training \[[@ref4],[@ref10],[@ref42],[@ref72],[@ref80],[@ref151]\], lack of time to learn how to use the new tools \[[@ref81],[@ref89],[@ref128],[@ref183]\], resources required to ensure the sustainability of training programs \[[@ref73],[@ref156]\], and training programs that focus solely on the technical side without addressing the workflow changes associated with mHealth use \[[@ref44],[@ref83],[@ref94],[@ref104],[@ref189],[@ref194]\] were among the most important training-related barriers. The significance of training is because of clinicians' need to develop new skills to be able to benefit from mHealth tools and embed them properly in their work practice \[[@ref65],[@ref70],[@ref77],[@ref92],[@ref122],[@ref154]\]. Proper training also helps achieve the highest potential of such tools, given that research shows that clinicians sometimes do not benefit from all available features simply because they were not aware of them \[[@ref150]\].

Factors related to workload and resource allocation were also central. Staff and resources availability and allocation were the main hurdle identified \[[@ref9],[@ref34],[@ref51],[@ref55],[@ref70],[@ref85],[@ref102],[@ref104],[@ref152], [@ref181],[@ref183],[@ref192]\]. Adequate staffing is considered a prerequisite for successful adoption \[[@ref2],[@ref61],[@ref77],[@ref78],[@ref92],[@ref185],[@ref189]\]. Some studies acknowledged that mHealth caused an increase in workload \[[@ref4],[@ref41],[@ref195]\] mostly because of double data entry caused by lack of integration and interoperability \[[@ref35],[@ref72],[@ref172]\], adjustment to new responsibilities and ways of working \[[@ref48],[@ref79],[@ref80]\], and poor workflow adaptability \[[@ref182]\]. Moreover, clinicians may refrain from adopting the tools altogether if they believe that they would increase their workload \[[@ref5],[@ref37],[@ref174]\]. This perception is sometimes triggered by their experience with other health IT systems, which added to their workload \[[@ref46]\]. At the same time, some studies reported no change in the overall workload because of mHealth adoption \[[@ref10]\], whereas others suggested that such technologies can alleviate workload where clinicians' recruitment and retention are challenging by improving efficiency \[[@ref73]\] and providing additional support and resources \[[@ref45],[@ref122],[@ref159],[@ref185],[@ref186]\].

*Fit* with the clinical practice and compatibility with workflow are also significant requirements for a successful adoption \[[@ref9],[@ref59],[@ref84],[@ref114],[@ref120],[@ref136],[@ref163],[@ref166],[@ref181],[@ref184]\]; accordingly, proper planning and integration \[[@ref8],[@ref10],[@ref61],[@ref73],[@ref182]\] and a good understanding of treatment processes \[[@ref78],[@ref129],[@ref172]\] are essential to avoid any disruption for clinical practice. Clinicians' perceptions that these technologies might negatively impact their work processes can hinder adoption \[[@ref46],[@ref53],[@ref80],[@ref141]\]. Such assessments are sometimes because of poor adaptability of the current routines to mHealth \[[@ref88],[@ref182]\]. Nonetheless, mHealth adoption can also sometimes result in workflow modification, where an adaptation of working patterns is necessary to harness the potential of such tools \[[@ref67],[@ref94],[@ref178]\]. These changes are mostly aimed at complementing routine care rather than replacing it \[[@ref70],[@ref180]\], and reorganizing work to warrant routine practice.[@ref39],[@ref40],[@ref122],[@ref150]

mHealth could enhance competitiveness through time and cost efficiencies, optimized work patterns \[[@ref1],[@ref54],[@ref59],[@ref74],[@ref86],[@ref109], [@ref152],[@ref161],[@ref188],[@ref190],[@ref195]\], quicker access to care \[[@ref91],[@ref137],[@ref159],[@ref162]\], and rapid triage and identification of cases that need urgent care thanks to the timely feedback that technologies such as digital patient monitoring enable \[[@ref5],[@ref47],[@ref52],[@ref57],[@ref87],[@ref115],[@ref157]\]. Consequently, it can allow clinicians to prioritize by enabling them to focus more on patients that need assistance versus more stable patients \[[@ref64],[@ref174]\]. Large scale rollout of such technologies also necessitates standardization, resulting in higher efficiency \[[@ref177]\]. Unfortunately, there are still cases where such tools do not result in better efficiency in practice \[[@ref94]\], mostly because of usability issues and difficulties with technology \[[@ref108],[@ref110]\] and lack of EMR integration resulting in double work and reenter of data, which eliminates the efficacy gains achieved with the tools \[[@ref44]\] and adds complexities to management \[[@ref39]\]. Sometimes, efficiencies such as less in-clinic visits or phone calls come at the expense of a higher overall workload when there is no appropriate reimbursement \[[@ref119]\]. Still, several studies suggested that the perceived higher efficiency can increase clinicians' intention to use mHealth \[[@ref61],[@ref78],[@ref107],[@ref132],[@ref140],[@ref150],[@ref181]\].

Improved collaboration and coordination among clinicians were among the identified facilitators \[[@ref1],[@ref52],[@ref68],[@ref109],[@ref150],[@ref152],[@ref186]\]. Well-planned coordination of services can increase adoption, especially when several teams or sites are involved \[[@ref2],[@ref8],[@ref88],[@ref162],[@ref176]\]. Better care coordination was also sometimes the result of the introduction of such technology \[[@ref87],[@ref194]\], mainly when new multidisciplinary and integrated teams are formed \[[@ref10],[@ref39],[@ref50],[@ref55],[@ref56],[@ref59],[@ref156],[@ref172],[@ref188]\], and peer support through second opinion and new models of shared decision making are created \[[@ref40],[@ref57],[@ref93],[@ref102],[@ref137],[@ref153],[@ref159],[@ref189]\]. Conversely, some studies report that this can sometimes result in more pressure on clinicians, as the tools increase the possibilities to coordinate and communicate with other staff members, adding to their already high workload \[[@ref46]\], and as interprofessional collaboration can be challenging \[[@ref85]\], sometimes resulting in lack of trust or conflicting opinions \[[@ref69],[@ref188]\]. The lack of coordination and collaboration was also seen as a barrier is some studies \[[@ref71],[@ref84],[@ref141],[@ref182],[@ref185]\].

Poor technical skills and experience create uncertainties about how the technology may work, thus they can be major hurdles for adoption \[[@ref37],[@ref55],[@ref59],[@ref67],[@ref81],[@ref127],[@ref143],[@ref153],[@ref179],[@ref184],[@ref191]\], whereas users' familiarity with the technology may create confidence that may foster adoption \[[@ref49],[@ref133],[@ref134],[@ref145],[@ref170]\]. The more IT-related knowledge and skills clinicians have, the lower their expected effort related to mHealth use becomes, resulting in an increase in their intention to use it \[[@ref9],[@ref96],[@ref129],[@ref149]\]. Also, those with previous digital health experience are usually more willing to embrace mHealth than their counterparts that had not used such tools before \[[@ref61],[@ref73],[@ref83],[@ref102],[@ref112],[@ref121],[@ref168]\]. However, it was also noted that in some cases, the fact that some clinicians use technology in their private life is not necessarily positively correlated with higher chances of technology adoption at the workplace \[[@ref122],[@ref146]\]. It is suggested that the staff's technical skills need to improve to enable the efficient use of such new technologies \[[@ref72]\].

Smooth integration of mHealth may necessitate changes in staff's roles and responsibilities \[[@ref56],[@ref62],[@ref65],[@ref67],[@ref72]\], sometimes in the form of alignment of duties \[[@ref48],[@ref86],[@ref152]\], role reassignment and redistribution \[[@ref2],[@ref94]\], expanding existing staff members' responsibilities \[[@ref85]\], or even the creation of additional functions or staff numbers to cover some of the new tasks related to mHealth management \[[@ref40],[@ref68],[@ref71],[@ref74],[@ref77],[@ref79],[@ref88],[@ref90],[@ref103]\]. It was noted that in some cases, the tools' introduction resulted in a lack of clarity on roles demarcation \[[@ref39],[@ref70],[@ref89],[@ref104],[@ref182]\], whereas clearly defined roles \[[@ref61]\] and the presence of a local *champion* that can guide others on the technology use can contribute to a successful adoption \[[@ref83],[@ref164]\]. The new tasks resulting from the use of such technologies are usually related to data analysis and interpretation \[[@ref60],[@ref74],[@ref176]\], monitoring patient data and alerting the relevant staff accordingly \[[@ref167]\], and also some other nonclinical tasks that were deemed sometimes undermining, such as equipment installation and troubleshooting \[[@ref80],[@ref82],[@ref189]\]. The tools, moreover, allowed the delegation of more tasks to nursing staff in several studies, giving them more autonomy and empowering them in their role \[[@ref78],[@ref169],[@ref183]\].

Leadership and institutional support were seen as a vital factor \[[@ref5],[@ref9],[@ref95],[@ref127],[@ref132],[@ref134],[@ref157],[@ref182],[@ref188],[@ref192],[@ref196]\] and considered one of the most important facilitators of technology adoption \[[@ref61],[@ref103],[@ref106],[@ref145],[@ref166],[@ref195]\]. Management support is crucial to facilitate the potential organizational changes that the new technologies entail, such as changes in roles and responsibilities \[[@ref40]\], or changes in workflow \[[@ref42],[@ref72],[@ref164]\], resource allocation \[[@ref73],[@ref131],[@ref170]\], and proper training \[[@ref111]\]. However, getting senior management support can be challenging at times \[[@ref34],[@ref138],[@ref174]\], resulting in lack of recognition of clinicians' activities taken with mHealth tools \[[@ref59]\]; this may be explained by a lack of proper understanding of mHealth from the management side \[[@ref178]\] or a false perception that such tools would detract staff from their real work \[[@ref156]\]. Lack of organizational support can be a barrier that slows down adoption \[[@ref71],[@ref86]\].

Organizational infrastructure is a basic prerequisite for mHealth success \[[@ref87],[@ref91],[@ref116],[@ref126],[@ref179]\]. Factors such as access to the internet, equipment, and suitable space and power play a key role in whether or not clinicians would adopt such new technologies \[[@ref4],[@ref47],[@ref51],[@ref69],[@ref77],[@ref93],[@ref124],[@ref127],[@ref153],[@ref154],[@ref163],[@ref169],[@ref181], [@ref187]\]. Poor infrastructure may hinder adoption \[[@ref35],[@ref70],[@ref82],[@ref83],[@ref151],[@ref172],[@ref193]\], as clinicians who have no access to suitable equipment may refrain from using mHealth \[[@ref2]\].

Process standardization and planning may facilitate the tools' uptake \[[@ref45],[@ref73],[@ref86],[@ref88],[@ref149]\]. This can be achieved via streamlined procedures \[[@ref39],[@ref80],[@ref160]\], process protocols and clear guidelines describing the practical details of integrating mHealth into clinical practice \[[@ref40],[@ref168],[@ref185]\], and the presence of internal responsibility for facilitating this standardization \[[@ref61],[@ref103],[@ref164]\]. Lack of planning or standardization of implementation strategies can hinder adoption as it can cause workflow challenges \[[@ref5],[@ref44],[@ref46],[@ref67],[@ref82]-[@ref84],[@ref155],[@ref167],[@ref189]\].

Staff nontechnical competence and qualifications also play a role in adoption \[[@ref2],[@ref73],[@ref84],[@ref91],[@ref156],[@ref164],[@ref185]\]. Factors such as knowledge of medical terminology, a good command of the language in which the tool is offered, and the capacity to review large amounts of data and using the complex charts produced by some of these tools are paramount for successful adoption \[[@ref4],[@ref36],[@ref109],[@ref176]\]. Given the shared decision-making models and higher collaboration enabled by mHealth, a potential hurdle may be the lack of confidence in the collaborators' clinical competence \[[@ref39],[@ref51]\]. Another subsequent difficulty is the fear of exposing knowledge gaps \[[@ref105],[@ref108],[@ref137]\] or being marginalized and undermined \[[@ref80]\]. Conversely, the fact that such tools enable less experienced clinicians to access clinical resources can also be a facilitator \[[@ref69]\].

The ability to efficiently manage and interpret the large amounts of data generated by mHealth, such as interpreting complex charts, may also impact adoption \[[@ref176]\]. Data management--related challenges can hinder the use of the tools \[[@ref51],[@ref177]\]. Factors such as information overload \[[@ref60],[@ref62],[@ref72]\] and the integration of the generated data in the existing workflow can be challenging \[[@ref53],[@ref167],[@ref182]\]. Other data-related risks, such as adverse events reporting and further handling, may also hinder adoption \[[@ref38]\]. Although such new technologies increase the potential to combine data to enhance patient monitoring and improve clinical decision making, some of the available tools do not give clinicians the flexibility to customize data reporting according to their specific needs \[[@ref36],[@ref120],[@ref183]\]. Facilitators include availability and access to required data \[[@ref66],[@ref77],[@ref100],[@ref150]\], higher efficiency of data analysis \[[@ref74],[@ref108]\], better patient care management because of the timely availability of data \[[@ref75],[@ref78],[@ref115],[@ref157]\], and the better ability to measure outcome \[[@ref73]\].

mHealth requires a change of paradigm that mostly results in changes to clinical practice \[[@ref48],[@ref59],[@ref65],[@ref92],[@ref186],[@ref189],[@ref192]\]. This is not necessarily a barrier to adoption; on the contrary, some studies show that clinicians are aware of the change that the technology entails and have already prepared themselves for it \[[@ref139]\]. This paradigm shift is linked to factors such as patients' self-monitoring and self-reporting, which necessitate new ways of treatment and care \[[@ref10],[@ref72],[@ref162],[@ref185]\]. However, this redistribution of roles can sometimes be challenging \[[@ref37],[@ref94],[@ref182]\]. For example, when a tool enables patients to access some of their test results before their care team, they can perceive this as an interference with established clinical practice \[[@ref46]\].

Clinicians' perceptions of mHealth's impact on their autonomy and job security may also influence adoption \[[@ref9],[@ref10],[@ref72],[@ref176],[@ref182],[@ref185],[@ref188]\]. Perceptions that the new tools compromise clinicians' autonomy, for example, by making their patients' treatment plans and outcomes more reachable to others and accordingly subject to more external control or criticism, may hinder adoption \[[@ref62],[@ref116],[@ref130],[@ref140],[@ref141],[@ref186],[@ref188]\]. This can be a considerable barrier to adoption when care teams perceive the new technology as a threat to their own career and livelihood \[[@ref55],[@ref72],[@ref141],[@ref151]\]. Equally, a tool has better chances of being adopted when perceived as a complement, not a substitute to clinicians' role \[[@ref62]\]. Some studies report that clinicians feel that they need to renegotiate their professional identities in the face of the *empowered and informed patient* that is sometimes seen as undermining the authority and credibility of the care teams \[[@ref10],[@ref62],[@ref72],[@ref80],[@ref182]\]. Conversely, it was also reported that mHealth can empower clinicians and help them be more autonomous, positively impacting adoption \[[@ref124]\].

Clinicians' empowerment is tightly linked to the possibility of positively impacting their professional development and expertise because of the use of these new technologies, especially among nursing staff \[[@ref62],[@ref72],[@ref124],[@ref162],[@ref169],[@ref188],[@ref189]\]. The educational benefits of mHealth for physicians can similarly encourage adoption \[[@ref137],[@ref161]\]. The tools are perceived as enablers that prompt for best practice care, provide novel decision aids, and expand clinical knowledge \[[@ref73],[@ref74],[@ref86],[@ref131]\].

Facilitating the adoption may be encouraged through proper incentives for clinicians \[[@ref4],[@ref88],[@ref106],[@ref122],[@ref164]\]. Incentives such as awarding continuing medical education, adding mHealth use as an objective in employee appraisals, offering financial rewards through improved reimbursement schemes, and more clarity around medico-legal topics may encourage use \[[@ref54],[@ref59],[@ref87],[@ref129],[@ref141],[@ref157],[@ref175],[@ref191]\].

Decision making can be a hurdle for adoption in the absence of a dedicated team or person responsible for digital health programs in the highly fragmented health care organizations \[[@ref4],[@ref102],[@ref160],[@ref191]\]. This can also be an obstacle when the official decision makers do not involve practitioners in defining the aims and objectives of the introduction of an mHealth tool \[[@ref43],[@ref71],[@ref72]\].

Social and Organizational Factors: Patient Related
--------------------------------------------------

Improvements in the quality and efficiency of care may positively impact clinicians' adoption of mHealth \[[@ref3],[@ref5],[@ref44],[@ref52],[@ref61],[@ref63],[@ref64],[@ref66],[@ref69],[@ref83],[@ref86],[@ref100],[@ref107]-[@ref109],[@ref120],[@ref122], [@ref125],[@ref127],[@ref140],[@ref166],[@ref168],[@ref175],[@ref182],[@ref186],[@ref196]\]. Such tools can improve the quality of patient care through better information access, improved disease control, personalized treatment plans, and more proactive support \[[@ref2],[@ref36],[@ref37],[@ref40],[@ref42],[@ref47],[@ref48],[@ref55]-[@ref57],[@ref72],[@ref78],[@ref80], [@ref88],[@ref92],[@ref93],[@ref103],[@ref114],[@ref115],[@ref119],[@ref130],[@ref157],[@ref159],[@ref160],[@ref162],[@ref174],[@ref184],[@ref188],[@ref190]\], although sometimes the perception that these new tools do not enhance patient care may hinder adoption \[[@ref3],[@ref10]\]. Clinicians raised some concerns about the quality of patient reports, the possibility of overtreatment, or false positives being reported through the tools \[[@ref38],[@ref183]\].

The impact of mHealth use on patient-clinician communication can also influence clinicians' adoption decision \[[@ref47],[@ref88], [@ref128],[@ref163],[@ref185],[@ref195]\]. This factor can be considered a facilitator when the tool enhances communication \[[@ref3],[@ref5],[@ref50],[@ref58], [@ref59],[@ref66],[@ref67],[@ref75],[@ref77],[@ref78],[@ref82],[@ref115],[@ref150],[@ref172],[@ref174],[@ref175],[@ref182],[@ref189]\], but it can also be considered a barrier when clinicians perceive the tool as an obstruction to their communications with their patients \[[@ref10],[@ref43],[@ref46],[@ref55],[@ref89],[@ref180]\]. Clinicians' concerns about digital communications are mostly about the loss of human contact, breaching patient privacy, medico-legal issues, unprofessional image, and patient's overreliance \[[@ref41],[@ref72],[@ref79],[@ref80],[@ref90],[@ref156],[@ref160],[@ref190]\]. It was also emphasized that such tools should complement rather than replace face-to-face treatment and therapy \[[@ref81],[@ref86],[@ref91]\].

Improving patients' access to care by removing time and space constraints may encourage clinicians' adoption \[[@ref1],[@ref3], [@ref5],[@ref8],[@ref43],[@ref64],[@ref73],[@ref82],[@ref129],[@ref130],[@ref156],[@ref162],[@ref174],[@ref182],[@ref184],[@ref190]\]. This is especially true when the tools allow underserved patients, those residing in rural or remote areas, or suffering from a chronic condition, to access health care services \[[@ref4],[@ref34], [@ref39],[@ref47],[@ref54],[@ref55],[@ref67],[@ref75],[@ref81],[@ref93],[@ref102],[@ref123],[@ref159],[@ref178],[@ref194]\]. mHealth may enable better access by eliminating or reducing travel burden \[[@ref2],[@ref4],[@ref60],[@ref62],[@ref78],[@ref91],[@ref169],[@ref187],[@ref195]\].

From the clinicians' perspective, patient consent, comfort, and preference play an important role in adoption \[[@ref2],[@ref9],[@ref39],[@ref49],[@ref90],[@ref104],[@ref122],[@ref123],[@ref132],[@ref153],[@ref185],[@ref192]\]. Several elements could impact patients' preferences, such as age, the complexity of the condition, access to technology, tech-savviness, or privacy concerns \[[@ref1],[@ref43],[@ref52],[@ref53],[@ref60],[@ref174],[@ref176],[@ref180],[@ref184],[@ref191],[@ref195]\]. In some cases, patients may feel more comfortable to use mHealth than face-to-face care when they are treated for sensitive conditions such as HIV or sexual health \[[@ref3],[@ref163]\].

It was reported that clinicians believe that mHealth may not be applicable or appropriate to all sorts of patients \[[@ref9], [@ref61],[@ref68],[@ref88],[@ref90],[@ref91],[@ref103],[@ref189]\]. Consequently, it is important to have balanced selection criteria \[[@ref71],[@ref79],[@ref89],[@ref162],[@ref182]\]. Some perceive the tools to be more appropriate for chronic and unstable patients that need more attention to support their stabilization \[[@ref41],[@ref66]\], although others deemed the technology inappropriate for those with physical or psychological impairments, severely ill patients, and the ones unable to properly use technology \[[@ref62],[@ref73],[@ref75],[@ref81],[@ref86],[@ref104],[@ref185]\]. However, it is important to note that restrictive inclusion criteria might prevent some patients who need the service from accessing it \[[@ref71]\].

Clinicians are more likely to adopt mHealth when it empowers and engages patients, giving them more autonomy and assurance about their disease or condition management \[[@ref5],[@ref34], [@ref44],[@ref48],[@ref62],[@ref73],[@ref77],[@ref78],[@ref88],[@ref89],[@ref115],[@ref157],[@ref166],[@ref175],[@ref180]\]. However, more evidence is needed to confirm such a positive impact on patient empowerment \[[@ref128]\]. It is also worth noting that in some contexts, patients may initially be anxious from such increased empowerment, as they are afraid of taking responsibility. However, research suggests that their confidence may develop with long-term support \[[@ref41]\]. Patient engagement might also be a barrier if they perceive mHealth as a burden, or when they do not feel that they need it \[[@ref70],[@ref71]\]

Safety concerns can impact intention to use \[[@ref72],[@ref103]\]. Perceived risks to patient safety can be a barrier to adoption, mainly when clinicians are concerned about factors such as device contamination, system reliability, clinical content accuracy, and self-diagnosing \[[@ref10],[@ref63],[@ref81],[@ref179],[@ref190]\]. Conversely, adoption may be encouraged when mHealth increases patient safety through timeliness, early detection, or clear documentation \[[@ref44],[@ref66],[@ref78],[@ref86],[@ref109],[@ref140],[@ref176],[@ref188],[@ref195]\].

The digital divide, defined in the Oxford dictionary \[[@ref198]\] as "the gulf between those who have ready access to computers and the Internet, and those who do not," also plays a role in the adoption. Clinicians are concerned about patients that might be marginalized because they lack access to technology, the elderly that do not use smartphones, those who have literacy issues, or a lower living standard \[[@ref49],[@ref53],[@ref55],[@ref60],[@ref73],[@ref75],[@ref79],[@ref81],[@ref84],[@ref120], [@ref123],[@ref138],[@ref185], [@ref191]\]. A study reported that nurses do not see patients' age as a barrier \[[@ref62]\].

Better patient education and awareness because of the use of mHealth tools may encourage adoption \[[@ref52],[@ref53],[@ref60],[@ref75], [@ref86],[@ref88],[@ref162],[@ref164],[@ref168],[@ref183],[@ref190],[@ref199]\]. However, clinicians were concerned that the convenience of the new tools might result in patients' overreliance on their practitioner support \[[@ref3],[@ref41],[@ref78],[@ref182]\]. Service abuse might occur when they overutilize the tool or try to access their care team after hours \[[@ref156],[@ref169]\], or if they become too dependent on technology and fail to seek medical help in case of emergency \[[@ref62],[@ref77]\].

Clinicians also pinpointed that data and surveillance-related anxiety might hinder adoption \[[@ref140],[@ref190]\]. Patients might worry excessively because of the large amounts of data available through mHealth \[[@ref46],[@ref128]\] or might feel watched because of the constant monitoring enabled by such tools \[[@ref62],[@ref78]\]. Furthermore, the sustainability of mHealth services depends on several factors, such as the willingness of patients to keep using it \[[@ref5]\], which might depend on the long-term availability of funding \[[@ref167]\] and clinicians' long-term commitment \[[@ref169]\]. It is also notable that clinicians might play a gatekeeping role for mHealth directly impacting adoption \[[@ref97]\]; this may be driven by their willingness to protect their patients from any added burden \[[@ref180]\].

Other Social and Organizational Factors
---------------------------------------

Concerns related to data privacy and security can be a barrier to adoption \[[@ref9],[@ref39],[@ref67],[@ref84],[@ref95],[@ref108],[@ref117],[@ref132],[@ref143],[@ref158],[@ref174],[@ref177],[@ref185], [@ref191],[@ref192]\]. Worries about confidentiality, fear of inappropriate data use, anonymity, and medico-legal risks were the main drivers of this \[[@ref2],[@ref3],[@ref10],[@ref37],[@ref47],[@ref49],[@ref52],[@ref53],[@ref59],[@ref98],[@ref100],[@ref102],[@ref110], [@ref123],[@ref128],[@ref130],[@ref152],[@ref160],[@ref163],[@ref167],[@ref178],[@ref182]-[@ref184],[@ref189],[@ref193]\]. mHealth was perceived to be more prone to data security issues compared with other forms of digital health tools because of its portability and accessibility from personal devices \[[@ref73],[@ref77],[@ref127]\]. Therefore, it is deemed important to have a safe tool that protects the data provided in it \[[@ref38],[@ref61]\], work out liability issues in advance \[[@ref60],[@ref131]\], provide data privacy training to clinicians \[[@ref138]\], and have clearer legal guidance \[[@ref161],[@ref162]\]. Interestingly, some studies reported that privacy concerns are not a key barrier to adoption, given that some clinicians that have high privacy concerns might still have high usage intentions \[[@ref125],[@ref142],[@ref149]\].

Policy and regulations mostly related to malpractice protection, licensing, and credentialing, in addition to costs and reimbursement issues, can certainly impact clinicians' adoption of mHealth tools \[[@ref9],[@ref10],[@ref37],[@ref61],[@ref73],[@ref95],[@ref121],[@ref123],[@ref130],[@ref141],[@ref151]\]. Unsuitable or inconsistent regulations and ambiguous policies \[[@ref5],[@ref35],[@ref63],[@ref155],[@ref159],[@ref179]\], restrictive directives \[[@ref64],[@ref102]\], lack of policies and protocols \[[@ref34],[@ref47],[@ref51],[@ref67],[@ref104],[@ref161],[@ref162]\], and lack of governmental coordination \[[@ref4]\] may hinder adoption. Clear and appropriate regulations and guidelines \[[@ref92],[@ref122],[@ref124], [@ref146],[@ref168],[@ref178],[@ref190],[@ref193]\] and more proactive involvement of governments and medical professional associations \[[@ref143],[@ref145],[@ref157]\] are essential for efficient adoption and sustainable services.

Clinicians' perceptions and attitudes toward technology may impact their decision to adopt the tools \[[@ref5],[@ref35],[@ref69],[@ref107], [@ref118],[@ref127],[@ref134],[@ref136],[@ref138],[@ref173]\]. Those who are lacking familiarity with mobile technologies, are resistant to change, or are risk averse may not use them \[[@ref34],[@ref60],[@ref67], [@ref85],[@ref108],[@ref117],[@ref174],[@ref186],[@ref195]\]; also, there is the perception that using a mobile phone at work may seem unprofessional \[[@ref63],[@ref124],[@ref190]\]. Those with positive attitudes toward technology are more likely to adopt new tools \[[@ref97],[@ref113]\]. In addition, their perception and attitudes toward mHealth specifically also affect their intention to use it \[[@ref10],[@ref95],[@ref109],[@ref111],[@ref130],[@ref132],[@ref133],[@ref147],[@ref178],[@ref185],[@ref188]\]. Clinicians with negative attitudes toward mHealth are more reluctant to use it \[[@ref143],[@ref155]\]. This is sometimes because of their perception that it will add to their workload \[[@ref37],[@ref83]\], their uncertainty to what the introduction of such new tools would mean for their workflow \[[@ref55],[@ref104],[@ref153],[@ref166]\], or their perception that it invades their privacy \[[@ref47],[@ref65],[@ref77],[@ref161],[@ref188],[@ref190]\]. It is also important to note that personal attributes such as adaptability and the readiness to try new things may similarly impact the adoption decision \[[@ref59],[@ref100],[@ref157]\].

The organizational culture and context can also impact the clinician's intention to use the tools \[[@ref95],[@ref151],[@ref168]\], although some studies reported that it is not a meaningful barrier \[[@ref130]\]. Prohibitive or unclear expectations around mobile phone use in the workplace may discourage adoption \[[@ref42],[@ref63],[@ref76], [@ref124],[@ref161],[@ref165],[@ref170],[@ref179]\]. Furthermore, an organizational culture that is resistant to change or risk averse may hinder the implementation of such new technologies \[[@ref45],[@ref86],[@ref148],[@ref176]\]. A cultural shift might be needed to enable and foster the acceptance of mHealth use at the workplace and transition from paper-based systems to more use of digital tools \[[@ref37],[@ref145],[@ref193]\].

Peer influence and endorsement are other factors that might impact clinicians' trust in mHealth and, accordingly, their adoption decision \[[@ref2],[@ref9],[@ref125],[@ref142],[@ref170],[@ref175],[@ref182],[@ref196]\]. Equally, those who are *change-resistant* may also impact early adopters negatively \[[@ref181]\]. Recommendations by reliable bodies such as scientific societies, renowned health care organizations such as the National Health Service, opinion leaders, internal champions, direct managers, or senior colleagues that promote the tools may foster adoption \[[@ref38],[@ref51],[@ref61],[@ref67],[@ref99],[@ref105],[@ref128],[@ref146],[@ref161],[@ref163]\].

Financial aspects are typically barriers to adoption \[[@ref70],[@ref101],[@ref152],[@ref168]\]. Lack of proper funding \[[@ref36],[@ref71],[@ref86], [@ref143],[@ref151],[@ref156],[@ref160],[@ref164],[@ref167]\] and compensation or reimbursement problems \[[@ref2],[@ref3],[@ref5],[@ref9],[@ref35],[@ref51],[@ref54],[@ref56],[@ref60],[@ref61],[@ref84],[@ref100],[@ref119],[@ref123],[@ref128]-[@ref130], [@ref184],[@ref186]\] usually hinder clinicians' intention to use mHealth. In addition, low awareness of existing reimbursement schemes \[[@ref102]\] and overcomplicated or inconsistent payment systems \[[@ref39],[@ref64],[@ref67],[@ref141],[@ref159],[@ref162]\] may also be a barrier. Conversely, a suitable payment model and health insurance coverage may encourage adoption \[[@ref8],[@ref67],[@ref68],[@ref77],[@ref92],[@ref122],[@ref131],[@ref182],[@ref195]\]. It is noteworthy that 1 study found that the financial disadvantages because of funding and reimbursement issues were compensated by the lower travel costs and higher efficiency generated by mHealth use \[[@ref91]\].

Reducing organizational costs may positively impact clinicians' adoption as it helps them achieve budget efficiency \[[@ref1],[@ref2],[@ref5],[@ref91],[@ref132],[@ref147],[@ref159],[@ref182]\]. However, uncertainties around cost-effectiveness \[[@ref34],[@ref41],[@ref73],[@ref78],[@ref114]\] and the actual tool's or service's charge and affordability \[[@ref9],[@ref38],[@ref39],[@ref51],[@ref53],[@ref55], [@ref60],[@ref61],[@ref63],[@ref64],[@ref67],[@ref84],[@ref110],[@ref123],[@ref142],[@ref147],[@ref156],[@ref191]\] may hinder adoption.

Clinicians' perception that the timeliness and amount of the data generated by mHealth can enhance the evidence for benefit is a facilitator \[[@ref85],[@ref89],[@ref108],[@ref109],[@ref115],[@ref159],[@ref169]\]. However, the perceived lack of a solid evidence base and proof of concept for clinical benefit resulting from mHealth use is considered a barrier to adoption \[[@ref5],[@ref43],[@ref60],[@ref69],[@ref73],[@ref84],[@ref160],[@ref162],[@ref175],[@ref188]\]. There is a need for more research about the outcomes of such technologies use in clinical practice to help foster adoption \[[@ref55],[@ref155],[@ref186]\].

The lack of awareness of mHealth tools may hinder adoption \[[@ref73],[@ref120],[@ref151],[@ref175]\]. Active promotion of the tools' existence and objectives \[[@ref9],[@ref55],[@ref56],[@ref150],[@ref156]\], and their benefits and impact on patient outcome may encourage their use \[[@ref2],[@ref38],[@ref43],[@ref61],[@ref89],[@ref131],[@ref149],[@ref168],[@ref180],[@ref182]\].

Engaging users in the development, planning, and implementation phases may positively impact their adoption decision \[[@ref68],[@ref86],[@ref135],[@ref169],[@ref172],[@ref183]\]. Enabling user feedback \[[@ref38],[@ref52]\], collaborative involvement, and codesign \[[@ref10],[@ref61]\] have shown to encourage adoption. Unfortunately, in some cases, clinicians are hardly asked for their input or involvement even though mHealth is one of their work tools \[[@ref72],[@ref182]\].

Moderating Factors
------------------

Some of the included studies reported that moderating factors, such as age, gender, specialty, and years of professional experience, may have an impact on clinicians' adoption intentions \[[@ref38],[@ref106]\]. However, other studies concluded that such moderating factors do not necessarily influence mHealth usage \[[@ref117],[@ref127],[@ref196]\].

Younger clinicians typically have a more positive attitude toward such new technologies compared with their older counterparts \[[@ref59],[@ref73],[@ref76],[@ref81],[@ref100],[@ref118],[@ref122],[@ref125],[@ref135],[@ref138]\], although some studies established that the age-gap does not play a role in adoption \[[@ref142],[@ref143]\]. Also, clinicians with previous digital health experience seem to have more favorable attitudes toward mHealth adoption compared with their counterparts that have no previous experience \[[@ref120],[@ref122],[@ref142]\].

Gender does not seem to be consistently reported as a moderating factor; 2 studies reported that female clinicians are more likely to accept the tools than their male counterparts \[[@ref134],[@ref143]\], whereas 1 study reported the reverse \[[@ref133]\]. The years of professional experience seem to negatively impact adoption \[[@ref111],[@ref118]\].

Conclusions and Implications
----------------------------

The systematic review findings indicate important guidelines and areas that must be targeted regarding social and organizational practices to promote and foster clinicians' adoption of mHealth tools successfully. As shown in [Figure 5](#figure5){ref-type="fig"}, these implications can be split into 3 categories to address the actions needed from 3 key stakeholders: policymakers, mHealth providers, and clinical decision makers.

![Implications for social and organizational practices. EMR: electronic medical record.](mhealth_v8i2e15935_fig5){#figure5}

Policymakers can play a crucial role in unleashing the potential of mHealth in clinical practice. This can be achieved through regulations that simplify and facilitate reimbursement and address data privacy and management issues. Incorporating mHealth in health insurance schemes can help solve the cost and payment barriers and encourage not only clinicians' adoption but also patients' use. Developing new remote care protocols may help practitioners standardize these new services and better integrate them into their clinical practice. It is also important to support the inclusion of mHealth-related skills in official medical education to ensure that new graduates will be equipped with all the necessary capabilities to successfully run such new technologies. Funding more research that contributes to a solid evidence base about the clinical and efficiency benefits and the added value of the new tools can foster their acceptance. Coordinating the different stakeholders to streamline and harmonize technology in a way that helps reach interoperability would also ensure the successful implementation of such tools and solve the issue of additional workload that sometimes results from a double entry in the different systems.

Such policy implications echo the findings of other researchers. For example, Davis et al \[[@ref183]\] addressed the barriers related to unclear legal liability and system interoperability. Gagnon et al \[[@ref9]\] also discussed the importance of cost-related barriers and the need to address them.

Providers and developers of mHealth tools should always proactively involve clinicians in the design, planning, and implementation of their services to ensure that it fits well into clinical practice. Facilitating user feedback is key to warrant the relevance and sustainability of the tool. Providing reliable training material about the tools' features, benefits, and workflow integration scenarios may help clinicians better integrate the new tools into their daily practice. Delivering tools that are useful and ease of use, and ensuring continuous technical support, is crucial for smooth day-to-day usage and to overcome any technical issues that might push users to abandon the tool. Working on solving interoperability and EMR integration issues would help them emphasize the efficiency gains resulting from their services that are sometimes compromised because of the burden of double data entry when systems are not integrated properly. Furthermore, engaging with reliable clinical associations and opinion leaders to endorse the tool can help create trust and accelerate the adoption.

Recommendations for providers and developers of mHealth tools are aligned with Brewster et al \[[@ref10]\], Davis et al \[[@ref183]\], and Radhakrishnan et al \[[@ref182]\] conclusions on the importance of the inclusion of clinicians in the development process to improve acceptance. Davis et al \[[@ref183]\] also shed light on the importance of system interoperability and EHR integration to facilitate adoption.

Clinical decision makers in hospitals and clinics need to support a cultural shift that promotes the benefits of technology and innovation to encourage their staff to change their traditional ways of working and embrace the new modalities. Facilitating mHealth training programs may help clinical staff acquire the new skills needed to successfully adopt the new tools. In addition, integrating mHealth in the clinical workflow is key to avoid that the tools become more of a hurdle to the staff. Encouraging the creation of multidisciplinary teams combining digital and clinical expertise and redefining the current roles to reflect the new skills needed to run the new technologies may contribute to a successful implementation. In some cases, the creation of new roles that support the implementation might be necessary.

In terms of implications for clinical decision makers, our findings are congruent with those of Duennebeil et al \[[@ref149]\], who emphasized the importance of establishing standards and treatment processes and training programs that would enable the adoption of such new tools. Training, promotion, and redefinition of roles were also highlighted by Brewster et al \[[@ref10]\] and Radhakrishnan et al \[[@ref182]\].

Limitations and Recommendations for Future Research
---------------------------------------------------

Although this study contributes to the understanding of the factors impacting clinicians' adoption of mHealth, some limitations must be acknowledged. This review may not have included relevant studies that were not indexed in the searched databases, written in a language other than English, and grey literature searches that could have also allowed the identification of additional relevant insights. However, this study meant to concentrate on peer-reviewed scientific papers.

Moreover, this analysis only considered published studies, and no further contacts were made with the papers' authors to obtain extra information or to validate our thematic analysis. Consequently, it is possible that other mHealth adoption factors might have been missed. Future reviews could include studies in other languages to have a better grasp of any interregional or intercultural differences, and to have more studies in developed countries.
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